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 ABSTRACT 
³<RXSUD\IRUJRRGKHDOWKDQGDERG\WKDWZLOOEHVWURQJLQROGDJHEXW\RXU 
                ULFKIRRGVEORFNWKH*RG¶VDQVZHUDQGWLH-XSLWHU¶VKDQG¶V 
                                                                                                         -PERSIUS 
STATEMENT OF THE PROBLEM: 
                ³ $ 678'<72$66(66 7+( ())(&7,9(1(662) $0/$   -8,&( ,1
REDUCING BLOOD  SUGAR AMONG   PATIENTS  WITH  TYPE  II  DIABETES IN A 
6(/(&7('$5($$71$0$..$/',675,&7´ 
OBJECTIVES:   
1) To assess the post prandial blood glucose level of patients  with  type II diabetes. 
2) To evaluate the effectiveness of amla juice consumption on the level of post prandial blood 
glucose level of patients with type II diabetes.                                                                                                  
3) To find out the association between the demographic an clinical variable with the post 
prandial blood glucose level of patients with type II diabetes.                                                       
4)  To assess the level of satisfaction among patients with type II Diabetes in experimental 
group about amla  juice  administration.    
Methodology:  
         The research approach used for this study was evaluative approach and the research design 
was true experimental design. 60 patients with type II diabetes, in that 30 in experimental group 
and 30 in control group were selected for this study by using purposive sampling technique. Data 
was collected with the help of self-structured interview schedule. Descriptive statistics 
(frequency, percentage, mean and standard deviation) and inferential statistics (chi-square, paired 
µW¶WHVWZHUHXVHGWRDQDO\]HWKHGDWDDQGWRWHVWK\SRWKHVLV 
MAJOR STUDY FINDINGS:      
       In experimental group the pre-test mean score was 2.966,mean percentage was 59% and 
standard deviation was 1.129 and in the post- test mean score was 2.533, mean percentage  was 
DQG VWDQGDUGGHYLDWLRQZDV ZLWK WKH HIIHFWLYHQHVV RI DQGSDLUHG µ W¶ WHVW
value of t=3.971 which was statistically significant (p<0.05) which is an evident for the 
effectiveness of amla juice in reducing blood glucose level. 
      The comparison between, blood glucose levels in experimental and control group, showing 
the value are statistically highly significant, ZKLFKZDVREVHUYHGIURPWKHXQSDLUHGµW¶WHVWYDOXH
of 13.39 with the p value of <0.05, which is an evident for the effect of amla juice in reducing 
post prandial blood glucose levels. 
CONCLUSION:  
         The study assessed the effect of amla juice in reducing blood sugar level among patients 
with type II diabetes. The result found was that amla juice is having effect in reducing blood 
glucose level after administration of amla juice for the experimental group. By comparing with 
experimental group and control group by pretest and post test, the effect was identified 
(assessed). The study concluded that the amla juice is effective  in reducing blood glucose level.                 
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                                                    CHAPTER-I 
                                                  INTRODUCTION 
     ³8QGHUVWDQGLQJWKHFKDOOHQJHV\RX face with your illness and the planning a 
OLIHGHVSLWHWKHPPD\EHRQHRIWKHKHDOWKLHVWGHFLVLRQ\RXZLOOHYHUPDNH´         
                                                                                                -LISA COPEN 
          Challenges in lifestyle, such as increases in energy intake and decreases in physical 
activity are causing overweight and obesity and leading to an epidemic increases in type II 
Diabetes Mellitus. Diets with low glycemic index (41) and for a low glycemic load diets are 
associated with a reduced risk of type II Diabetes. As the world wide incidence of diabetes is 
increased two to four fold, the search for dietary adjuncts to treat this life altering disease has 
become for ranging. 
The dietary components beneficial in the prevention and treatment of these diseases have 
not been clearly defined, but it is postulated that some home remedies may play a role .Botanical 
products can improve glucose metabolism and the overall conditions of individuals with diabetes 
not only by hypoglycemic effects but also by improving lipid metabolism, antioxidant status, and 
capillary function. A number of medicinal or culinary herbs have been reported to yield 
hypoglycemic effects in patients with diabetes. 
Diabetes mellitus (DM) also known as simply diabetes is a group of metabolic diseases 
in which there are high blood sugar levels over a prolonged period .This high blood sugar 
produces the symptoms of frequent urination, increased thirst and increased hunger. Untreated 
diabetes can cause many complications. Acute complications include Diabetic Ketoacidosis and 
Non Ketotic Hyperosmolar coma. Serious long time complications include heart disease, stroke, 
kidney failure, foot ulcers and damage to the eyes. 
Diabetes is due to either the pancreas not producing enough insulin, or the cells of the 
body not responding properly to the insulin produced. 
There are three main types of Diabetes Mellitus, 
     Type I DM: 5HVXOWVIURPWKHERG\¶VIDilure to produce enough insulin, also known as 
³,QVXOLQ±GHSHQGHQWGLDEHWHVRU-XYHQLOHGLDEHWHV´ 
     Type ll DM: Begins with insulin resistance a condition in which cells fail to response 
to insulin properly. Sometimes combined with an absolute Insulin deficiency.  
    Gestational Diabetes: It is the third main form and occurs when pregnant women 
without a previous history of diabetes develop a high blood glucose level.  
 All forms of diabetes have been treatable .Since insulin became available in 1921 and 
type II diabetes may be controlled with medications. Both types I and II are chronic conditions 
that usually cannot be cured. Pancreas transplant have been tried with limited success in type II 
diabetes mellitus, gastric bypass surgery has been successful in many with morbid obesity and 
type II Diabetes mellitus. 
       Gestational diabetes usually resolves after delivery. Diabetes without treatment can 
causse many complications. Acute complications include hypoglycemic, diabetic ketoacidosis or 
non- ketotic hyperosmolar coma. Serious long term complications include cardiovascular 
disease, chronic renal failure and retinal damage. Adequate treatment of diabetes in thus 
important, as well as blood pressure control and lifestyle factors such as smoking cessation and 
maintaining a healthy body weight. 
AMLA: 
Amla belongs to Phyllanthaceae family of trees. It also known as Indian gooseberry. The 
botanical name of the amla is emblica officinalis. There are several other names of amla in 
different languages of india, like for instance it is called 
 Nellikkai in tamil and kannada 
Nellika in malayalam 
Amla in hindi and gujarat 
Amla is the medium size deciduous plant. It grows to the height of 8-18meters. It has a 
crooked trunk and spreading branches. Its flower is yellow greenish in colour. The fruit is 
spherical pale yellow with six vertical furrows the average weight of the fruits is 60-70g. 
  It is planted through the deciduous of tropical India and on the hill slopes upto 
2000 meters. It is also grown in Tamilnadu, Rajasthan, Madhya Pradesh also. 
The Amla fruit is rich in vitamin C (ascorbic acid) is a source of invaluable minerals such 
as calcium ,magnesium ,potassium ,iron ,copper, and  as well as source of amino acids. 
In addition to its generally healthy properties of amla has positive effects on the pancreas, 
where insulin is produced, and its content of chromium helps to manage blood sugar level.  
 
NEED FOR THE STUDY: 
India is diabetes capital of the world.  
In India, diabetes is not an epidemic any more but had turned into a pandemic, according 
to the International journal of diabetes in developing countries which labeled  India the diabetes  
capital of the world. This is mainly because India now has the highest number of patients with 
type II diabetes in the world. 
The international diabetes federations estimate that the number of   diabetes patient in 
India more than doubled from 19 million in 1995 to 40.9 million in 2007. It is projected to 
increase to 69.9 million by 2025. 
 Currently up to 11 percent of ,QGLD¶VXUEDQSRSXODWLRQDQGSHUFHQWRIUXUDOSRSXODWLRn 
above the age of 15 has diabetes.  
Various studies have shown that the high incidence of diabetes in India is mainly because 
of sedentary lifestyle, lack of physical activity, obesity, stress, and consumption of diets rich in 
fat , sugar and calories. 
The most prevalent is the type II diabetes, which constitutes 95 percent of the diabetic 
population in the country. 
 Diabetes affects all people in the society, not just those who live with it. The world 
health organization estimates that mortality from diabetes and heart disease cost India about 840 
billion in the every year and is expected to increase to& 335 billion in the next ten years. These 
estimates are based on lost productively, resulting primarily from premature death. So with such 
a huge population of patient with type II diabetes, the country is known as the diabetes capital of 
the world.  
 According to the university of Maryland Medical center Indian gooseberry/Amla is an 
effective traditional remedy which contains chromium, a mineral that regulates carbohydrate 
metabolism and may make the body more responsive to insulin helping to keep blood sugar at 
healthy level.  
Akhtar et al., evaluated the anti-hyperglycemic and lipid-lowering properties of  amla  
fruit, in normal, as well as diabetic human volunteers. The results indicated a significant decrease 
in fasting and 2 hours post-prandial blood glucose levels on the 21 st day in both normal and 
diabetic subjects receiving 1, 2 or 3 g amla powder  per day as compared with their baseline 
values. Significant decreases were also observed in TC and triglycerides in both normal and 
diabetic volunteers on day 21 that were given either 2 or 3 g amla powder per day.   Both normal 
and diabetic volunteers receiving 2 or 3 g amla powder significantly improved high-density 
lipoprotein-cholesterol and lowered low-density lipoprotein-cholesterol levels.  
Ruitang deng, 2012 conducted randomized, controlled trial to evaluate the effect of 
emblica officinalis on glycaemic control.120 patients were randomly assigned into two groups 
.The treatment group received a teaspoon of amla juice and control group received normal diet. 
At the end of the study fasting blood sugar levels were significantly decreased in treatment 
group, whereas no changes were detected in control group.                                                                                      
Behradmanesh Saeed, A double-blind clinical trial was carried out on 80 type II diabetic 
patients who had not reached the ideal control of the disease. Patients were randomly divided 
into two equal groups of case and control. The case group received emblica officinalis and the 
control group received placebo tablets three times a day for three months. The fasting blood 
sugar (FBS and 2 hours postprandial (2hpp glucose were checked at the beginning and every 2 
weeks. The 2nd hour post prandial blood sugar and cholesterol levels were significantly 
decreased in emblica officinalis treated patients compared to control group. 
Shamim et.al., reported that phyllanthus species which were found to involve in 
regeneration and rejuvenation of beta cells leading to an increased insulin production and 
secretion which decreases the blood sugar.                                                                                                             
Biswas Gopa. Conducted a study on control of hyperglycaemia and hyperlipidemia. He 
administered amla extract for 40 patients daily for 42 days. After the day of enrolement all 
patients were followed up twice during the 42 days period. Blood samples were analysed for 
various biochemical parameters. In view of above findings amla produced significant 
hypolipidemic and hypoglycaemic effect, these results indicates the usefulness of amla in the 
managements of diabetes.  
Results from several additional case series also suggest amla may improve glycemic 
control in patients with type II diabetes mellitus. It also be easily available. The investigator felt 
that continuous intake of amla juice may help the patients to lead a normal life without diabetic 
drug. This motivated the investigator to choose the study.  
  
 
 
FACTS ABOUT DIABETES; 
The  prevalence  of   diabetes  had  reached  epidemic  proportions.                                                             
WHO  predicts   that  developing  countries  will  bear  brunt  of  this  epidemic  in  the  
21st  century .currently, more  than  70  percent  of  people  with diabetes  live  in  low  and  
middle  countries.                                                                                                                                  
$Q HVWLPDWHG PLOOLRQSHRSOHFRUUHVSRQGLQJ WR  SHUFHQW RI  WKHZRUOG¶V
adult  population  will  live  with  diabetes  in  2010.  The  number  is  expected  to  grow  438  
million  by  2030,  corresponding  to  7.8  percent  of  the  adult  population. 
While  the  global  prevalence  of  diabetes  is  6.4 percent,  the  prevalence   varies  from  
10.2  percent  in  the  Western  pacific  to  3.8  percent  in  the   African  region. However , the  
African  region  is  expected  to  experience  the  highest  increases. 
70% of the current cases of diabetes occur in low and middle income countries. With an 
HVWLPDWHG  PLOOLRQ SHRSOH OLYLQJ ZLWK GLDEHWHV  ,QGLD KDV WKH ZRUOG¶V ODUJHVW GLDEHWHV
population, followed by china with 43.2 million. 
 
  
 
 
STATEMENT; 
       "A study to assess the effectiveness of amla juice in reducing blood sugar among 
patients with type II diabetes in selected area at  Namakkal district."  
OBJECTIVES: 
1) To assess the post prandial blood glucose level of patients with  type II diabetes. 
2) To evaluate the effectiveness of amla juice consumption on the level of post prandial 
blood glucose level of patients with type II diabetes.                                                                                     
3) To find out the association between the demographic an clinical variable with the post 
prandial blood glucose level of patients with type II diabetes.                                                       
4)  To assess the level of satisfaction among patients with type II Diabetes in experimental 
group about amla juice administration.     
HYPOTHESIS;  
All the hypothesis will be tested at 0.05 level                                                                      
H1: There will be significant difference between the blood sugar readings before and after the 
intake of amla juice in the experimental group 
H2: There will be significant difference between the post-test blood sugar of type 2 diabetic 
patients in the experimental and control group. 
H3: There will be significant association of the mean blood sugar reading with selected 
baseline factors like age, sex, occupation, nature of work, type of family, duration of 
illness, regularity of taking medications, sleeping hours, and exercise.   
    
OPERATIONAL DEFINITIONS; 
Assess:  
It is the action of making a judgment about the value or quality of something. In this 
study the word assess refers to the process of checking the post prandial blood glucose level of 
patients with type II diabetes to note the effectiveness of amla juice. 
Effectiveness  
Effectiveness is the outcome of amla juice administration with regard to reduction in post 
prandial blood glucose level. 
Diabetic patient: 
Diabetic patient refers to the clients the age group of 35 to 60 years are diabetes mellitus. 
It fasting blood sugar greater than 120mg/dl. 
Amla juice:  
The extract from the amla fruit (approximately 60g) is mixed with 100ml of water and it 
is administer for 15 days. 
Home remedy: 
A home remedy is to treat the diabetes mellitus by amla juice to reduce blood sugar level 
in diabetic clients.  
ASSUMPTION: 
  Diabetes is a significant  public health problem.   
 Early detection ,improves delivery of care and better education for self management can 
reduce much of coplications.  
 Amla contains components that have hypoglycemic activities. 
DELIMITATIONS: 
      The patients with type II diabetes who care willing to participate in the  
       study. 
       Who had post prandial blood glucose level more than 140mg/dl 
      Who were able to understand local language. 
      Those who were on medications.[oral hypoglycemic agent].  
                                                                                                            
 
 
 
  
 
 
 
CONCEPTUAL FRAMEWORK 
The conceptual framework for research study presents the reasoning on which the 
purposes of the proposed study are based. The framework presents the perspective from which 
the investigator views the problems. 
The conceptual framework deals with the inter-related concepts that are assessable 
together in same rational schemes by virtue of their relevance to a common theme 
(polit&Beck,2004).  
7KHFRQFHSWXDOIUDPHZRUNRIWKHSUHVHQWVWXG\LVEDVHGRQZLHGHQEDFK¶VKHOSLQJ$UWRI
clinical nursing theory (1964). 
The conceptualization of nursing practice according to this theory consists of 3 steps. 
Step 1 ± Identifying the need for help.   
 Step 2 -  Ministering the needed help.  
Step 3 ± Validating that the need for help was met. 
Step 1:   Identifying the need for help:  
Identification involves individualization of the patient experiences and recognition of the 
SDWLHQW¶VSHUFHSWLRQRIKLVFRQGLWLRQ 
In this study, the determination of the need for help is by the process of sample selection 
on basis of inclusion and exclusion criteria followed by the pre-assessment of hyperglycemia 
among selected patients. 
 
    
 Step 2:  Ministering the needed help: 
Ministration is providing the needed help. In ministering, the nurse may give advice or 
information, make referral and apply a comfort measure or carryout a therapeutic procedure. It 
has two components, 
-Prescription 
-Real 
Prescription: 
3UHVFULSWLRQ UHIHUV WR WKHQXUVH¶VSODQRISDWLHQWV FDUH$SUHVFULSWLRQPD\ LQGLFDWH WKH
broad general action appropriate to implementation of the basic concept as well as suggest the 
kind of   behavior needed to carry out these actions in accordance with the central purpose. 
This includes administration of amla juice along with medication for patients in 
experimental group for 15 days to administer only medications for patients in control group. 
Realities: 
Are situation that influences the fulfillment of central purposeZLHGHQEDFK¶VGHILQHV
realities as; 
Agent                                                                                                                                          
The agent is the practicing nurse or her delegate, who is characterized by the personal 
attributes, capacities, and competencies in nursing.  
 
Recipient: 
The recipient, the patient is characterized by the personal attributes, problems and ability 
to cope with concerns or problems being experienced. Patients with type II diabetes are the 
recipients in this study.  
Goal: 
 The goal the desired outcome the nurse wishes to achieve. The goal is the end result 
to be attained by the nursing action. Goal in this study is to reduce the level of hyperglycemia. 
Measures and Activity: 
 It comprises the activities and devices through which the practitioner is enabled to 
attain her goal. It includes skills, techniques, procedures, and devices that may be used to 
facilitate nursing practice. 
                     In this study, means refers to preparation oh amla juice and administering it to the 
experimental group for a period of 15 days. 
Framework: 
                     Framework consist of human, environmental, professional and organizational 
facilities. Framework for this study is selected community area at namakkal district. 
 
 
 
Step 3:  Validating that the need for help was met: 
 Validating is evidence that the patients functional ability was restored as a result of the 
help given. 
 This was done by the post assessment of hyperglycemia followed by analyzing the 
findings. 
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                                                CHAPTER-II 
REVIEW OF LITERATURE 
³:HPXVWWXUQWRQDWXUHLWVHOIWRWKHREVHUYDWLRQRIWKHERG\LQKHDOWKDQG in disease to 
OHDUQWKHWUXWK´ 
                                                                        -HIPPOCRATES 
Review of relevant literature as evidence is the essential background for any research. It 
refers to both the activities involved in searching for information on a topic as well as to the 
actual written report the summarizes the state of the existing knowledge on a topic in generally 
facilitated by the use of various obstructive and indexing services.    
Literature review is the key step in the research process. Polit and hungler defined review 
RI OLWHUDWXUH DV ³$EURDG FRPSUHKHQVLYH, in depth, systematic and critical review of scholarly 
publications, unpublished scholarly printed materials, audio visual material and personal 
FRPPXQLFDWLRQ´ 
According to Basavanthappa, ³,t refers to an extensive, exhaustive, systematic 
examination of publications relevant WRWKHUHVHDUFKSURMHFW´ 
The investigator did an extensive review of the research and non research literature 
related to the present study and made on attempt to contribute to a deep insight into problem area 
and methodology .In order to accomplish the goal in the present study, an attempt has been made 
to review and discuss the literature under following sub heading.  
      
        (i)  Literature related to incidence and risk factor of diabetes.   
       (ii) Literature related to properties of Amla  
       (iii) Literature related to amla juice administration as a complimentary alternative therapy 
for hyperglycaemia 
I  Literature related to incidence and risk factors of diabetes: 
Carole willi et al ., (2006), conducted a systematic review and meta analysis of studies 
describing the between active smoking and the data indicated that active smokers have a 44%, 
increased risk of developing type II diabetes compared with in non smokers. 
Peter Nilsson ,et al ,(2004) A prospective , population based study in Maldives ± 
Sweden was conducted on incidence of diabetes in middle aged men related to sleep disturbances 
the study result revealed that all together , 28 (4.3%) men developed diabetes and concluded that 
sleep disturbances and possibility elevated heart rate , in middle aged men are associated with 
increased risk of diabetes.    
Motala ,et al (2004), conducted a prospective community study in a south African Indian 
cohort (which continued  for 10 years) from Durban showed a higher incidence in 563 subjects. 
Elise et al (2002) stated that 4,549 participates were examination in a study on incidence 
of diabetes in American Indians of 3 geographic areas in the year 2002, in which 3,638 returned 
for a similar examination  after an average of 4 years, the high incidence rates found in this study  
were alarming and they recommended preventive programs to reduce the risk of progressive to 
diabetes. 
Mohan et al (2005) , a longitudinal population based study on incidence of diabetes and 
pre diabetes on a selected urban south Indian population (ups-19) was conducted , in which he 
found that among subjects with normal glucose tolerance 48 (10.1%) developed pre-diabetes.the 
incidence rate of diabetes was very high among urban south Indians , while obesity, abdominal 
obesity and hypertension were associated withdiabetes.   
American dental association , (2005), reported 6.2% of the us population having 
diabetes it can be expected to have more than 120 diabetes patients visits per year. This includes 
the 5% of diabetes patients who are type 1 and the 95% who are type II and the incidence of 
diabetes is growing dramatically. 
Professional N. Viswanathan ,(2004) reported endowment public lecture on diabetes 
2004 ± in the world and in India by   proof .lefebbre , according to him, in2003, there was 189 
million diabetes in the world . the projected figure for 2020 is 324 million.  
Dowre, 1996, conducted a study to assess the incidence of diabetes in the pacific and 
Indian ocean population. The study reported that the highest incidence rates (above 15 cases 
11000 person years)were more observed in the pima Indians , rural wangles of Papua , new  
guinea , nanruens urban Samoans and Indians in Mauritius. Dowre had predicted that continuing 
modernization and increasing obesity in heavily populated region of the Indian , sub-continent , 
Africa and china may produce epidemics of diabetes.         
 
 
 
II.  Literature related to properties of amla:  
Nain et.al, 2012,  stated that amla have been shown to act as a hypoglycaemic agent. The 
unique dietary fibre composition and high chromium content in amla appears to be responsible 
for these therapeutic properties. 
 Suryanarayan et.al, stated that amla and isolated amla fractions have been shown to  
concluded that amla have been reported to be beneficial for treating type II diabetes. Mechanism 
such as the stimulating or regenerating effect of beta cells  will secrete the insulin to reduce the 
blood sugar. 
 Bhardwaj 1994, conducted a study on, control of hyperglycaemia and hyperlipidemia by 
plant product among patients with type II diabetes. Oral glucose tolerance test showed 
improvement. The serum total cholesterol low density lipoproteins cholesterol also reducrd 
significantly. 
 K.H Khan conducted that oral administration of the amla extracts reduced the blood 
sugar level in both animal and human subjects and an enriched fraction of tannoids are effective 
in the management of diabetes. 
 Raaz k Maheswari et.al, described that administration of amla juice extract with bitter 
gourd juice for two months will stimulate the pancreas to secrete insulin,thus decreasing blood 
sugar in diabetes due to its high vitamin c content,is effective in controlling  diabetes mellitus. 
 Virendra Yadav et.al, conducted a systemic review on the role of selected Indian plants 
in management of the type II diabetes. They concluded that amla have been reported to be 
beneficial for treating type II diabetes. Mechanisms such as the stimulating or regenerating effect 
on beta cells of extra pancreatic effects are proposed for the hypoglycaemic action of these herbs. 
Sikha et.al, described that  the aqueous extract of amla seeds was investigated for its 
anti-diabetic activity in Streptozotocin induced type 2 diabetes animal models. They concluded 
the dose of 300 mg kg-1 of aqueous seed extract in sub- and mild-diabetic animals produced a 
maximum fall of glucose level in the blood . 
 Walia K and Boolchandani R, stated that the nutritive value and medicinal properties of 
amla used in improving blood glucose metabolism in type II diabetes. They concluded that amla 
supplement is effective in reducing the fasting and post prandial blood glucose levels and 
HbA1C levels. 
III. Literature related to Amla juice administration as a complimentary alternative therapy 
for hyperglycaemia :                                             
Jagatkumar bhatt. Conducted a study on control of hyperglycaemia and hyperlipidemia. 
He administered emblica officinalis extract for 40 patients daily for 42 days. After the day of 
enrolment all patients were followed up twice during the 42 days period. Blood samples were 
analyzed for various biochemical parameters. In view of above findings amla produced 
significant hypolipidemic and hypoglycemic effect, these results indicates the usefulness of amla 
in the managements of diabetes.  
Snehal.et.al, evaluated the anti hyperglycemic and lipid lowering properties of emblica 
officinalis fruit in normal and diabetic human volunteers. The results indicated a significant 
decrease in fasting and 2hrs post prandial blood glucose levels on the 21st day in both normal and 
diabetic subjects receiving 1,2,or3 amla powder per day as compared with their baseline  values. 
Significant decreases were also observed in total cholesterol and triglycerides in both normal and 
diabetic volunteers on day 21 that were given either 2or3g amla powder per day. 
 Directory of open access journal Sweden, This study was performed to investigate the 
hypoglycemic effect of emblica officinalis on blood glucose. A double blind clinical trial was 
carried out on so type II diabetic patients who had not reached the ideal control of the disease. 
Patients were divided into two equal groups of case and control. The case group received 
emblica officinalis and the control group received placebo tablets three times a day for three 
months. The fasting blood sugar and 2hr postprandial were checked for every 2weeks.there was 
significant decreases in 2hr postprandial blood sugar in emblical officinalis treated patients 
compared to control group. So it showed that emblica officinalis might be beneficial in diabetic 
patients.    
Prasan R Bhandari, conducted a study diabetic patients to reduce the blood. Glucose 
levels by amla extract. The subjects were randomly assigned into two groups, treatment and 
control. The treatment group took a medium sized fresh amla on a daily bases while the control 
group received no supplementation for 2 months. During the course of study ,no modification in 
the diet or medication was made in both groups . it revealed that a emblica officials is effective 
in lowering blood glucose levels in diabetic patients.     
K.V santhi sri.et,al, To study the effect of amla in type 2 diabetic selected 60 to DM 
subjects, devided into 2 groups, control group and experimental group. The experimental group 
of 30 patients was given a medium sized fresh amla on a daily basis for 6 months. They were 
asked to consume the fruit daily before breakfast. During the course of supplementation no 
modification in the diet or medication was made for both experimental and control groups. At the 
end of the supplementation the biochemical parameters like FBS, PPBS and lipid profile were  
monitored. One medium size amla for 6 months led to a significant decrease in the FBS, PPBS, 
lipid profile values in the experimental group. There were no significant changes in the control 
group. Sabu and kuttan 2002 hakim et al 1996 conducted a study to assess the hypoglycemic 
effect of emblica officinalis. They administered oral supplementation of amla extract which 
reduced the blood sugar level of patients with type II diabetes. 
 Shekella,et.al,2005, A systematic review of trials was conducted on the ayurvedic herbs 
for diadetes. They found that there is evidence to suggest that the amla has a glucose cover 
effect.  
Nahas R, moher M, 2009, Canada , described the complementary and alternative 
medicine for the treatment of type II diabetes. To review clinical evidence supporting 
complementary and alternative medicine interventions for improving glycemic control in  type II 
diabetes mellitus. Fibre, green tea, amla and fenugreek have other benefits but there is evidence 
that they substantially improve glycemic control. Further research on bitter melon and cinnamon 
is warranted. 
Reetesh et. al The aqueous fruit extract of Phyllanthus emblica showed effect on typeII 
diabetes, triglycerides (TG) and liver specific enzyme, alanine transaminase (ALT). It was 
shown that aqueous fruit extract in a dose of 200mg/kg body weight, significantly decreased the 
EORRG JOXFRVH OHYHO DIWHU LW¶V LQWUDSHULWRQHDOO\ DGPLQLVWUDWLRQ LQ DOOR[DQ LQGXFHG GLDEHWLF UDWV
The aqueous extract also induced hypotriglyceridemia by decreasing TG levels in diabetic rats. 
In addition, the extract was also found to improve liver function by normalizing the activity of 
liver specific enzyme alanine transaminase (ALT). 
Mehta et al., a maximum reduction of 27.3% in the blood glucose level was observed at 
the 6 h time point in fasting blood glucose studies in normal rats after the administration of 300 
mg kJí%: RI DQ DTXHRXVH[WUDFW RI DPOD seeds. The same dose produced a 25.3% drop in 
normal rats during the glucose tolerance test (GTT) at 3 h after glucose gadministration and a 
maximum reduction of34.1%and41.6%comparedto the control group in sub- and mildly diabetic 
animals, respectively.  
       
Krishnaveni et al. (2010) , conducted the antidiabetic  activities of amla and  its extract 
have been studied in animal models and humans. They  found that oral administration of an 
ethanol extract of  amla fruit (200 mg kg-1BW for 45 days) resulted in a significant reduction in 
blood glucose and a significant increase in plasma insulin in streptozotocin (STZ)-induced type 2 
diabetic rats. In addition,  with an ethanol extract of amla fruit showed a significant reduction in 
blood lipid levels and an elevation in HDL cholesterol  levels.  
 
Nampoothiri et al. (2011) conducted a study on type 2 diabetes which revealed that an 
extract of  Phyllanthus embilica IUXLW ZDV DEOH WR LQKLELW ERWK HQ]\PHV  Į-amylase DQG Į-
glucosidase significantly more efficiently than that of a reference compound . These results may 
mechanistically explain some of the anti-diabetic effects of  Phyllanthus emblica. 
 
S.A. Kalekar et al(2013),In a recent , invitro study showed that amla possess insulin 
sensitizing and glucose stimulatory activity. A hyro-DOFRKROLFH[WUDFWRI3HPEOLFDȝJPO
was found effective to stimulate glucose uptake in adipocyte cells in 3T3L1 adepocyte cell  
culture. 
Jai prakash et. Al, Oral administration of 75% methanolic extract (100 mg/kg body 
weight) of Emblica officinalis fruit to normal and alloxan induced diabetic rats, resulted in 
significant lowering of serum glucose level in 4 hours. In another investigation on ethyl acetate 
extract of the fruit (20 and 40mg/ kg/day) when given orally for 20 days to streptozotocin 
diabetic rats, significantly improved glucose metabolism. The hydro methanolic extract of leaves 
of Emblica officinalis showed antidiabetic effect in streptozotocin-induced type 2 diabetes 
mellitus in rats. Emblica officinalis fruit was evaluated for anti-hyperglycaemic and lipid-
lowering properties in human volunteers. The results indicated a significant decrease (P <0.05) in 
fasting and 2hpost-prandial blood glucose levels on the 21st day in both normal and diabetic 
subjects receiving 1, 2 or 3 g of amla fruit.  
 
Sharma S et. al, The hypoglycemic effect was measured by blood glucose and plasma 
insulin level. Oral administration of the amla at a concentration of 100, 200, 300 and 400 mg/kg 
b.w. daily for 45 days showed a significant (P<0.05) decrease in fasting blood glucose and 
increase insulin level as compare with the diabetic subjects. Also it significantly (P<0.05) 
reduced all biochemical parameters (serum creatinine, serum urea, SGOT, SGPT and lipid 
profile). The treatment also resulted in a significant (P<0.05) increase in reduced glutathione, 
glutathione peroxidase, superoxide dismutase, catalase, and decrease LPO level inthe liver and 
kidney of diabetic subjects. 
         
Dr. R.Agarwal,  conducted a randomised double blind placebo controlled study to 
evaluate the safety and effectiveness of  polyherbal powder (Sugaradik) in achieving glycaemic 
control in newly diagnosed type 2 diabetics. Eighty newly diagnosed patients of type 2 diabetes 
were selected after meeting inclusion and exclusion criteria. Patients were randomly divided into 
two groups. One group received drug and other group received placebo bearing a distinctive 
code number. Anthropometric parameters and HbA1c were performed initially as well as after 
three months of treatment period. Fasting blood sugar and blood pressure were recorded weekly. 
After three months of treatment of polyherbal powder (Sugaradik) there was a significant 
improvement in systolic blood pressure (136.05±3.30 to126.42±1.51 mmHg) and fasting blood 
sugar (233.03±8.81to 136.16±4.96 mg/dl; p less than 0.001). There was a significant reduction in 
HbA1c (8.39±0.30 to 6.37±0.10percent; p less than 0.001). No adverse effects were observed in 
this trial. He concluded that Polyherbal preparation of ten classic herbs  appears to be effective in 
controlling glycemia. Sugaradik seems to be a safe drug and an effective oral agent in the 
management of type 2 diabetes. 
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CHAPTER-III 
METHODOLOGY 
³$PDQWRREXV\WRWDNHFDUHRIKLVKHDOWKLVOLNHDPDFKLQHWRREXV\WRWDNHFDUHRIKLVWRROV´ 
                                                                            -Spanish Proverb 
Methodology is the major phase of research in which the investigator makes a number of 
decisions about the methods and materials to be used to study the research problems basically 
through the collection of data. These methodological decisions generally hare several 
implications for the reliability of the study finding. 
            [polit and hungler 1999] 
This chapter deals with the methodological approach adopted for the study. The purpose 
of the study is to assess the effectiveness of amla juice on reduction of blood glucose levels in 
patients with type II diabetes. 
The methodology includes description of research approach research designs , site and 
settings, sampling technique, development of the tool , validation of the tool and reliability, 
methods of data collection , pilot study and plan for statistical analysis. 
RESEARCH APPROACH: 
Research approach is the most significant part of any research. The appropriate choice of 
the research approach depends on the purpose of the research study is under taken.  
According to polit and hungler (1999) evaluative research is an extremely applied form 
of research and involves finding out how well a policy is working. Its goal is to assess or 
evaluate research is generally applied where the primary objectives is to determine the extent to 
which a given treatment meets the desired results.  
To accomplish the objectives of this study an evaluative approach is considered most 
appropriate, since the researcher want to assess the effectiveness of amla juice upon 
hyperglycemia. 
REASEARCH  DESIGN:                                                                                                                         
 The research design refers to the researchers overall plans for obtaining answers to the 
research questions and for testing the research hypothesis. The research design spells out the 
strategies that the researcher adopts to develop information that is accurate, objective  and 
interpretable [polit and hungler 1999]. 
A true experimental research design was adopted for conducting this study. It sfulfils the 
criteria such as randomized, manipulation and control. 
SCHEMATIC REPRESENTATION OF THE RESEARCH DESIGN: 
 
 
R 
 
 
R = Randomization 
         O1 = Pre assessment of hyperglycemia 
         O2 = Post assessment of hyperglycemia 
          X = Amla juice administration 
          E =  Experimental group 
          C = Control group 
VARIABLES: 
Variables are the qualities, properties or characteristics of person. Things of situation that 
change or vary. 
GROUP 
 
 
PRE 
ASSESSMENT 
INTERVENTION POST 
ASSESSMENT 
E O1 X 
 
O2 
C O1 - 
 
O2 
The variables mainly include in the study are dependent variables independent variables and 
extraneous variables. 
¾ Dependent variables: 
It is the response, behaviour or outcome predicted or explained in research (Kothari 
CR,2004). 
In this study, the dependent variable is post prandial blood glucose level of patients with 
type II diabetes. 
¾ Independent variables: 
An independent variable is the treatment or experimental activity that is manipulated or varied by 
the researcher to create an effect on the dependent variable(Kothari CR,2004). 
In this study, the independent variable is the intake of amla juice.                           
¾ Extraneous variables: 
Extraneous variables in this study are age, gender, marital status, religion, education, 
occupation, income, dietary habits, regular exercise. 
SITE AND SETTING: 
The setting selected for the present study is kuppandapalayam and sanarpalayam 
community area at Namakkal  district. 
POPULATION:                                                                                         
According to Polit and Hungler, Population refers to the entire aggregation of cases that 
PHHWVGHVLJQHGFULWHULD´7KHUHTXLUHPHQWRIGHILQLQJDSRSXODWLRQ for a research project arises 
from the need to specify the group to which the study can be performed. 
The population for the present study is patients with type II diabetes in kuppandapalayam 
and sanarpalayam community area at Namakkal district. 
 
SAMPLE: 
          The samples are patients with type II diabetes who met the eligible criteria. 
SAMPLING TECHNIQUE: 
Sampling technique is defined as the process of selecting a group of the elements with 
which to conduct. In this study, purposive sampling technique is used. 
SAMPLE SIZE:  
The proposed sample size for the study is 60 patients. In that 30 were experimental group 
and 30 were control groups 
SAMPLING CRITERIA 
INCLUSION CRITERIA: The study will include patients who, 
x Have post prandial blood glucose level above 140mg/dl. 
x Have type II diabetes on treatment with oral hypoglycemic drugs. 
x Are above the age of 30 years 
x Patients who understand Tamil or English. 
x Patients, who are willing to participate, 
EXCLUSION CRITERIA 
x Patients with type I diabetes mellitus. 
x Patients associated with bronchial asthma, sinusitis. 
x Patient who are unwilling to participate. 
x Patient with type II diabetes who are on insulin. 
x Patients with peptic ulcer, diabetic complications such diabetic nephropathy, retinopathy 
and ischemic artery disease.                                                                                                                                        
                 
                     SCHEMATIC REPRESENTATION OF THE STUDY DESIGN 
                
 
 
 
                         Systematic Random Sampling  
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                            Fig 3.1: schematic representation of the study design 
TARGET POPULATION    
patients with type II diabetes 
ACCESSIBLE  POPULATION                                   
Patients in selected area at namakkal district
        SYSTEMATIC RANDOM SAMPLING                                      
Experimental Group                   
30 patients with type II diabetes 
    Control  Group                      
30 patients with type II diabetes 
Pre assessment  of               
hyperglycemic  level 
Assessment of   
hyperglycemic level 
Administration of Amla juice 
along with  routine therapy 
Post assessment of hyperglycemic level 
Level of satisfaction on Amla juice  
Repeated assessment of     
hyperglycemic level 
  Analysis and Interpretation by descriptive and inferential statistics 
                    EFFECTIVENESS  OF  AMLA  JUICE 
 SELECTION OF THE TOOL: 
In the present study semi structured interview was used  to collect the socio-demographic 
data. 7KH5DWLQJVFDOHZDVGHYHORSHGWRDVVHVV SDWLHQW¶VVDWLVIDFWLRQDERXWDPOD MXLFHDQG WKH
blood glucose assessment chart to record the Post prandial blood glucose level. 
DEVELOPMENT OF THE TOOL; 
The following steps were carried out in formulation of the tool. 
1) Related literatures were required. 
2) Blue print prepared. 
3) Guidance and consultation of the subject experts were taken and alternations were made 
accordingly. 
4) Consultations with statistician was done for the preparation of the plan for statistical data 
analysis. 
5) Reliability was checked during pilot study. 
6) Calibration of glucometer was done for measuring the blood glucose levels 
 
Review of literature includes related  review of journals, articles and books published and 
unpublished research studies. They were reviewed and used for the development of the tool. 
The blue print was prepared to construct the tool which consists of 9 demographic 
variables and 5 clinical variables, blood glucose assessment chart and rating scale on satisfaction 
of amla juice. 
DESCRIPTION OF THE TOOL 
Tool consists of three sections. 
Section 1 :  Demographic and clinical variables of the patients with Type II diabetes. 
Section 2 :  Blood glucose assessment chart. 
Section 3 :  Rating scale. 
 
SECTION 1 : 
Demographic variables proforma: 
It consist of selected demographic variables like age, gender, marital status, religion, 
education, occupation, income per month, dietary habits and regular exercise. 
Clinical variable proforma: 
Clinical variables consist of duration of illness, weight in kgs, basal metabolic index, 
family history of diabetes and management of diabetes. 
SECTION 2 : 
 BLOOD GLUCOSE  ASSESSMENT  CHART:                                                               
This  assessment chart is used to record the post prandial  blood glucose scoring before 
and after  intervention from the patients with  type II diabetes.     The total maximam score for 
the items was 5.                                                                          
Score interpretation:     
          Range            PPBG       Scoring 
<140 mg/dl Normal                    1 
141-210 mg/dl Mild                    2 
211-280 mg/dl Moderate                    3 
281-350 mg/dl Severe                    4 
>351 mg/dl Very severe                    5 
 
 THIRD SECTION 
 Rating scale on satisfaction of amla juice:. 
In this, rating scale is used to assess the satisfaction level of patients with type II diabetes 
who is taken for experimental group. The scoring is awarded according to the satisfaction level. 
The maximum scoring for satisfaction is 4.       
Score Interpretation: 
         < 25%    -   Not satisfied. 
         25-50% -   Satisfied. 
         51-75% -   Moderately satisfied. 
         >75%     -   Highly satisfied. 
RELIABILITY OF THE INSTRUMENT: 
 Reliability of research instrument is defined as extent to which the instrument yields the 
same results on repeated measures. It is then concerned with consistency, accuracy, precision, 
stability equilance. The observation was conducted for a 6 patients with type II diabetes. The 
reliability of the tool was established by testing the consistency.  
                                                                                                                                                                      
VALIDATION OF INSTRUMENT:  
The validity refers to whether a measuring instrument accurately measures what it is 
supposed to measure. 
The content validity of the tool will be ascertained in consultation with experts in the 
field of medical surgical nursing. The experts were requested to give their opinion regarding 
reliance, appropriateness and degree of agreement in each items in the tool. Suggestions and 
recommendations given by the experts will be considered and modification of tool will be done. 
PILOT STUDY: 
           A pilot study is a small preliminary investigation of the same general characteristics as the 
PDMRU VWXG\ ,W LV GHVLJQHG ³WR DFTXDLQW  WKH UHVHDUFKHUZLWK WKH SUREOHPV WR EH FRUUHFWHG LQ
SUHSDUDWLRQIRUWKHODUJHUUHVHDUFKSURMHFWDQGWU\RXWWKHSUREOHPVIRUFROOHFWLQJWKHGDWD´3LORW
study was conducted to ensure validity and reliability and feasibility for giving intervention.  
 
The pilot study was conducted in kuppandapalayam community area at Namakkal 
district, after getting formal permission from the principal. In this study 6 samples will be 
selected by getting prior permission. A purposive  sampling technique will be used to select the 
sample. 3 samples in experimental group and 3 in control group who fulfilled the inclusion 
criteria other than the main study sample area. The data analysis will be done by using 
descriptive statistics. 
ETHICAL CONSIDERATION 
Prior to data collection the permission will be obtained from the Principal of college of 
Nursing and oral consent will be obtained from the samples. Confidentiality will be maintained. 
DATA COLLECTION PROCEDURE 
x Prior to the data collection, permission will be obtained from the concerned authority for 
conducting the study. 
x Subjects will be selected according to the selected criteria and confidentiality will be 
assured. 
x Written informed consent will be obtained from the subject.  
x The investigator will collect the baseline proforma and check the pre-test blood sugar of 
clients on Day 1 using the glucometer 
x The investigator will instruct the experimental group clients about amla juice 
consumption. 
x Experimental group consumes amla juice from Day-2 for 15 days. 
x Client will record the daily intake of amla juice daily in the compliance diary. 
x The investigator would recheck the blood sugar level of clients using the              
      glucometer   on Day 7 and again on Day 16. 
Instruments intended to be used 
The instruments intended to be used in this study are: 
x Baseline Proforma 
x Glucometer, strip and needle 
x Compliance diary 
x Blood sugar proforma 
x Rating scale for satisfaction. 
PLAN FOR DATA ANALYSIS  
Data will be collected and observed from 60 patients with type II diabetes who are in 
kuppandapalayam and sanarpalayam community area. The gathered data will summarized and 
tabulated, grouped and analyzed by utilizing bio statistical methods of both descriptive (which 
includes mean, percentage, standard deviation) and inferential statistics (which includes chi- 
VTXDUHWHVWSDLUHGµW¶ test).    
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CHAPTER  IV 
ANALYSIS AND INTERPRETATION 
INTRODUCTION:   
This chapter presents the analysis and interpretation of the data collected to determine the 
effect of amla juice on the post prandial blood glucose level of patients with type II diabetes. 
Kerlinger (1995) defines analysis as the category, ordering manipulating and 
summarizing of data to obtain answers to research question. 
Data was collected from 60 samples who were patients with type II diabetes. 
STATISTICAL ANALYSIS:   
              The data obtained was classified, tabulated and the following analysis was performed in 
fulfilling the objectives of the study. The data analysis involves the translation of the information 
collected during the course of the research project into interpretable, convenient and descriptive 
terms and to draw inferences from them using statistical methods. The purpose of analysis is to 
summarise, compare and test the proposed relationship and inferential findings. 
OBJECTIVES THE STUDY:  
1) To assess the post prandial blood glucose level of patients with type II diabetes. 
2) To evaluate the effectiveness of amla juice consumption on the level of post prandial 
blood glucose level of patients with type II diabetes.                                                                                     
3) To find out the association between the demographic an clinical variable with the post 
prandial blood glucose level of patients with type II diabetes.                                                       
4)  To assess the level of satisfaction among patients with type II Diabetes in experimental 
group about amla  juice  administration.     
 
   
The data collected from the type II diabetes mellitus patients are organized, analysed and 
presented under the following headings: 
SECTION  I:      i) Distribution of demographic variables of respondents.  
                           ii) Distribution of clinical variables of respondents. 
SECTION  II:    
Assessment of the post prandial blood glucose levels of patients with type II diabetes in 
the experimental and control group before and after intervention. 
SECTION  III:  
Association between demographic and clinical variables with the post prandial blood 
glucose levels in patients with type II diabetes in the experimental and control group. 
SECTION  IV:  
Assessment of the level of satisfaction among patients with type II Diabetes in 
experimental group about amla  juice  administration.     
 
   
 
 
 
 
 
 
 
 
 
SECTION  I:        
i) DISTRIBUTION OF THE DEMOGRAPHIC VARIABLES 
  This section deals with the analysis of the data collected from 60 patients with typeII 
diabetes based on their specified inclusion criteria and enplaned in frequency and percentage are 
represented.   
                     Table 4.1 : Frequency and percentage distribution of sample  
               Demographic variables Experimental 
group 
  Control group 
   F     %     F       % 
               Age    31-40 years    6    20%    7      23% 
41-50 years    10    33%    8      27% 
51-60 years    11    37%    9      30% 
>60 years    3            10%    6       20%   
Gender Male    14     47%    13       43% 
Female    16     53%    17       57% 
Marital  status Married    19     63%     20       67%    
Unmarried     5     17%    6        20% 
Divorced     2      7%    3       10% 
Widow/Widower     4      13%    1        3% 
Religion Hindu     15       50%    18        60% 
Christian     12      40%     6       20% 
Muslim      3     10%     6       20% 
Others     -      -     -       - 
Education Uneducate     2      7%     5        17% 
Primary     7     23%     6        20% 
High school     8     27%     7        23% 
Higher secondary     7     23%     6         20% 
 
 >15,001      3      10%     4       13% 
Occupation Business     8      27%     5       17% 
Govt .Employee     6      20%     4       13% 
Private sector     9      30%      9       30% 
Others     7      23%     12       40% 
Dietary habits Vegetarian     5      17%      4       13% 
Non Vegetarian    25      83%     26       87% 
On regular 
exercise 
Yes    22      73%     19       63% 
No     8      27%     11       37% 
 
The data presented in the above table is according to age of patients in experimental 
group 6(20%) samples are in the age group of 31-40 years, 10(33%) in the age group of 41-50 
years, 11(37%) in the age group of 51-60 years, 3(10%) in the age group of above 60 years. 
Similarly, in control group 7(23%) in the age group of 31-40 years, 8(27%) in the age group of 
41-50 years, 9(30%) in the age group of 51-60 years and 6(20%) in the age group of above 60 
years.   
The gender of patients in experimental group 14(47%) of samples are male and 16(53%) 
of samples are female patients. Similarly, in control group 13(43%) of samples are male and 
17(57%) of samples are female patients. 
 It is observed that according to the marital status of patients in experimental group 
19(63%) of samples are the married, 5(17%) of  samples are unmarried, 4(13%)  of samples are 
widower/widower and 2(7%) of samples are divorced. Similarly, in control group 20(67%) of 
samples are the married, 6(20%) of samples are unmarried, 1(3%) of samples are 
widower/widower and 3(10%) of samples are divorced.  
      According to religion of patients in experimental group 15(50%) of samples are the 
+LQGX¶VRIVDPSOHVDUH&KULVWLDQ¶VRIVDPSOHVare Muslims and other religion 
KDYHQRVDPSOHV6LPLODUO\LQFRQWUROJURXSRIVDPSOHVDUHWKH+LQGX¶V
RIVDPSOHVDUH&KULVWLDQ¶VRIVDPSOHVDUH0XVOLPVDQGRWKHUUHOLJLRQKDYHQRVDPSOHV
(0%). 
That data presented in the above table  is that according to the educational status of 
patients in experimental group 2(7%) of samples are uneducated, 7(23%) of samples are the 
primary education, 8(27%) of samples are the high school education, 7(23%) of the samples are 
higher secondary education and 6(20%) of the samples are graduate and above.other. Similarly, 
in control group . 5(17%) of samples are uneducated, 6(20%) of samples are the primary 
education, 7(23%) of samples are the high school education, 6(20%) of the samples are higher 
secondary education and 6(20%) of the samples are graduate and above other. It  is observed 
from the above  that according to income per month of the patients  in experimental group 
12(40%) of samples are in the income of less than Rs.5000/month , 10(33%) of samples are in 
the income of Rs.5001-10,000/month, 5(17%) of samples are in the income of Rs.10,001-
15,000/month and 3(10%) of samples are in the income of more than 15,000/month.  Similarly, 
in control group 11(37%) of samples are in the income of less than Rs.5000/month, , 9(30%) of 
samples are in the income of Rs.5001-10,000/month, 6(20%) of samples are in the income of 
Rs.10,001-15,000/month and 4(13%) of samples are in the income of more than 15,000/month.   
 That data presented in the above diagram  is that according to the occupation of patients , 
in experimental group 8(27%) of samples are doing business, 6(20%) of samples are working as 
government employee , 9(30%) of samples are working in private sector, 7(23%) of the samples 
are coming under other occupation. Similarly, in control group, 5(17%) of samples are doing 
business, 4(13%) of samples are working as government employee, 9(30%) of samples are 
working in private sector, 12(40%) of the samples are coming under other occupation. 
The data presented in the above diagram represents dietary habits of patients, in 
experimental group 5(17%) of samples are vegetarian and 25(83%) of samples are non 
vegetarian patients. Similarly, in control group 4(13%) of samples are vegetarian and 26(87%) of 
samples are non vegetarian patients. 
The data presented in the above diagram is according to on regular exercise of patients, in 
experimental group 22(73%) of samples are on regular exercise and 8(27%) of samples are not 
on regular exercise. Similarly, in control group 19(63%) of samples are on regular exercise and 
11(37%) of samples are not on regular exercise.  
  
 
 
 
 
 
 
 
 
  Table 4.2 : Frequency and percentage distribution of clients on selected  
        clinical variables  
  
              Clinical  variables Experimental 
group 
  Control group 
   F     %     F       % 
               
Duration of 
illness                
<1 year     6    20%    6      20% 
1-2 years     6    20%    7      23% 
>2 years    18    60%    17      57% 
Weight in kgs 31-40     3           10%     2       7%   
41-50     7    23%     6       20% 
51-60    12    40%     8       27% 
>60     8    27%    14       46% 
    BMI < 18.4     3     10%      2       7%    
18.5-22.5     7     23%    6        20% 
22.6-29.9     12     40%    8       27% 
>30     8     27%    14        46% 
Family history 
of diabetes 
 
 Father     7      23%     6       20% 
Mother     6     20%     5       17% 
Uncle     2      7%     3       10% 
Other relation     2      7%     2       7% 
No    13     43%    14       46% 
Management 
of illness(DM) 
Diet & exercise       -     -     -        - 
Insulin     -     -     -        - 
2+$¶V     8     27%    11        37% 
Both a & c    22     73%    19        63% 
                                                                                                                                                    
 
 
  
                    Fig 4.1: Bar diagram showing the distribution of patients   
                                   according to duration of illness  
 
 
 
 That data presented in the above diagram  is that according to the duration of illness, in 
experimental group 6(20%) of patients are having illness less than 1 year, 6(20%) of patients are 
having illness for 1-2 years, 18(60%) of patients are having illness more than 2 years.  Similarly, 
in control group. 6(2o%) of patients are having illness less than 1 year , 7(23%) of patients are 
having illness for 1-2 years, 17(57%) of patients are having illness more than 2 years. 
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              Fig 4.2: Cylindrical  diagram showing the distribution of patients 
                                                   according  to  weight. 
 
  
  
 
 That data presented in the above diagram  is that according to weight in kilogram of 
patients , in experimental group 3(10%) of patients are weighing between 31-40kgs , 7(23%) of 
patients are weighing between 41-50kgs , 12(40%) of samples are weighing between 51-60kgs, 
8(27%) of the patients are weighing more than 60kgs. Similarly, in control group, 2(7%) of 
patients are weighing between 31-40kgs, 6(20%) of samples are weighing between 41-50kgs , 
8(27%) of patients are weighing between 51-60kgs, 14(46%) of the patients are weighing more 
than 60kgs 
 
0%
20%
40%
60%
80%
100%
31-40
41-50
51-60
> 60
10%
23%
40%
27%7%
20% 27%
46%
%
  o
f  
pa
tie
nt
s
Weight   in  kgs
Experimental group Control group
  
       .    
 
 
             Fig 4.3: Pyramidal  diagram showing the distribution of patients  
                                          according to Basal Metabolic Index 
 
                   
                               
  
 That data presented in the above diagram is that according to basal metabolic index 
of patients, in experimental group 3(10%) of patients are less than 18.4, 7(23%) of samples are 
between 18.5-22.5, 12(40%) of patients are between 22.6-29.9, 8(27%) of the samples are  more 
than 30. Similarly, in control group, 2(7%) of patients are less than 18.4, 6(20%) of patients are 
between18.5-22.5, 8(27%) of patients are between 22.6-29.9, 14(46%) of the patients are more 
than 30 BMI. 
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                        Fig 4.4: Conical diagram showing the distribution of  patients  
                                          according to Family history of diabetes. 
 
 
 
 That data presented in the above diagram  is that according to the family history of 
diabetes of patients, in experimental group 13(43%) of patients are not having family history of 
diabetes, 7(23%) of patients are having family history from father, 6(20%) of patients are having 
from mother, 2(7%) of the patients are having from uncle and other relations. Similarly, in 
control group . 14(46%) of samples are not having family history of diabetes , 6(20%) of samples 
are having family history from father, 5(17%) of patients from mother and 3(10%) of the 
samples from uncle and 2(7%) of the patients from other relations 
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                    Fig 4.5: Pyramidal  diagram showing the distribution of patients 
                                          according to Management of diabetes. 
 
 
 
 That data presented in the above diagram  is that according to the management of illness 
of patients, the result of  experimental group showing that 22(73%) of patients are on both oral 
hypoglycemic agents and diet and exercise , 8(27%) of patients are  only on oral hypoglycemic 
agents. Similarly, in control group showing that 19(63%) of patients are on both oral 
hypoglycemic agents and diet and exercise, 11(37%) of  patients are  only on oral hypoglycemic 
agents. 
  
 
0%
20%
40%
60%
80%
100%
Diet
&exercise Insulin OHA's
Both a & c
0%
0%
27%
73%
0%
0%
37%
63%
%
  o
f  
pa
tie
nt
s
Management  of  illness[DM]
Experimental group Control group
  SECTION  II: 
ASSESSMENT OF THE POST PRANDIAL BLOOD GLUCOSE LEVELS 
OF PATIENTS WITH TYPE II DIABETES IN THE EXPERIMENTAL 
AND CONTROL GROUP BEFORE AND AFTER INTERVENTION: 
              An attempt had been made to assess the effect of amla juice  on blood glucose level of 
patients with type II diabetes in the experimental and control group. After collecting the post 
prandial blood glucose levels in both experimental and control groups before and after 
intervention the average score are calculated. Based on the post pradial  blood glucose levels 
those were graded as normal, mild, moderate, severe, and very severe. 
Table 4.3: Assessment of post prandial blood glucose level of  patients with type II diabetes 
in the experimental and control group: (Before intervention) 
 
S.No 
 
PPBG level 
scoring 
      Experimental group         Control group 
Frequency  Percentage Frequency  Percentage 
   1 Normal 
(<140) 
      4       13%        3        10% 
   2    Mild   
(141-210) 
      6        20%                 9       30% 
   3  Moderate 
(211-280) 
       8        27%         8        27% 
  4 Severe  
(281-350) 
       11        36.67%          7        23% 
   5 Very severe 
(>351) 
        1        3.33%          3        10% 
 Total        30         100%            30         100%     
 
 The above table 3 showing the frequency and percentage distribution of patients 
according to the post prandial blood glucose level  patients with type II diabetes in the 
experimental and control group: (Before intervention). 
 
Fig 4.6: Cylindrical diagram showing the distribution of post prandial blood glucose level 
of patients with type II diabetes in the experimental and control group: (Before 
intervention):    
 
 
 That data presented in the above diagram  is that according to the post prandial blood 
glucose level of patients, in experimental group 4(13%) of patients had normal post prandial 
blood glucose level, 6(20%) of patients had mild post prandia blood glucose level, 8(27%) of 
patients had moderate post prandial blood glucose level, 11(36.67%) of the patients had severe 
post prandial blood glucose level and 1(3.33%) of patient had very severe post prandial blood 
glucose level. Similarly, in control group . 3(7%) of patients had normal post prandial blood 
glucose level , 9(30%) of patients had mild post prandial blood glucose level ,8(27%) of samples 
had moderate post prandial blood glucose level  7(23%) of the samples had severe post prandial 
blood glucose level and 3(10%) of the samples had very severe post prandial blood glucose level.
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Table 4.4: Assessment of post prandial blood glucose level of  patients with type II diabetes 
in the experimental and control group: (After  intervention) 
 
 
S.No 
 
PPBG level scoring 
      Experimental group         Control group 
Frequency  Percentage Frequency  Percentage 
   1 Normal (<140) 
 
      8       27%        2        7% 
   2    Mild  (141-210) 
 
      7        23%                   6       20% 
   3  Moderate (211-280) 
 
       9        30%         10        33% 
  4 Severe (281-350) 
 
       4        13%          9        30% 
   5 Very severe(>351) 
 
       2         7%          3        10% 
     Total 
 
       30         100%              30         100%       
 
 The above table 4 showing the frequency and percentage distribution of patients 
according to the post prandial blood glucose level  in the experimental and control after 
intervention.  
 
 
 
 
 
Fig 4.7: Pyramidal diagram showing the distribution of post prandial blood glucose level of 
patients with type II diabetes in the experimental and control group: (After intervention): 
 
 
 
 That data presented in the above diagram  is that according to the post prandial blood 
glucose level of patients, in experimental group 8(27%) of patients had normal post prandial 
blood glucose level, 7(23%) of clients had mild post prandia blood glucose level, 9(30%) of 
clients had moderate post prandial blood glucose level, 4(13%) of the samples had severe post 
prandial blood glucose level and 2(7%) of clients had very severe post prandial blood glucose 
level. Similarly, in control group . 2(7%) of clients had normal post prandial blood glucose level 
, 6(20%) of clients had mild post prandial blood glucose level ,10(33%) of clients had moderate 
post prandial blood glucose level  9(30%) of the clients had severe post prandial blood glucose 
level and 3(10%) of the clients had very severe post prandial blood glucose level. 
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Table 4.5: Score of postprandial blood glucose level of experimental group: 
  
  
PPBG 
level 
score 
  
           
Over all  
score 
            Pre-test score       Post-test score 
 
  Mean Mean 
%       
  SD 
 
 Mean     Mean   
% 
   SD 
      5 
 
   2.966     59%    1.129    2.533    50.66%   1.074 
 
 The above table 4 showing the result of the experimental group of  patients  with type II 
diabetes postprandial blood glucose level of pre-test and post-test overall score. Before 
implementation the score was high and after implementation the postprandial blood glucose 
scoring was reduced. Overall   postprandial blood glucose level  score showing decreased from 
59% - 50.66%. 
Fig 4.8 : Pyramidal diagram showing the score of postprandial blood glucose level of 
experimental group: 
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Table 4.6:Score of postprandial blood glucose level  of control group: 
  
PPBG 
level 
score 
  
           
Over all  
score 
            Pre-test score       Post-test score 
 
  Mean Mean 
%       
  SD 
 
 Mean     Mean   
% 
   SD 
      5 
 
   2.933     58.6%    1.172    3.166    63.3%   1.085 
 
 The above table 5 showing the result of the control group of  patients  with type II 
diabetes postprandial blood glucose level of pre-test and post-test overall score. Before 
implementation the score was high and after implementation the postprandial blood glucose 
scoring was not at all reduced and  postprandial blood glucose level  score showing increased 
from 58.6% - 63.3%. 
Fig 4.9: Conical diagram showing the score of  postprandial blood glucose level score of 
control  group: 
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 The overall table concluded that the effectiveness of amla juice in patients with type II 
diabetes which reduces the blood glucose level, after consuming , the blood glucose level reveals 
the net benefit of this study which indicates the effectiveness of amla juice administration. 
7DEOH3DLUHGµW¶WHVWVKRZLQJVLJQLILFDQWGLIIHUHQFHEHWZHHQSRVWSUDQGLDOEORRG
glucose level  of patients with type II diabetes in experimental group: 
Experimental  
   group 
 
Overall  
score 
 Mean  Mean 
    % 
   SD   Effect   t  test  P  value 
Pre-test 
 
      5     2.966    59%   1.129          
 
   8.34 
 
 
   3.971 
          
P<0.05 
significant post-test 
 
      5     2.533   50.66%   1.074 
 
 The above table reveals that in experimental group the pre-test mean score was 
2.966,mean %  was 59% and standard deviation was 1.129 and in the post- test mean score was 
2.533, mean % was 50.66% and standard deviation was 1.074 with the effectiveness of 8.34% 
DQGSDLUHGµW¶WHVWYDOXHRIW 6RLWLVFRQVLGHUHGDVVLJQLILFDQW 
 
7DEOH3DLUHGµW¶WHVWVKRZLQJVLJQLILFDQWGLIIHUHQFHEHWZHHQSRVWSUDQGLDOEORRG
glucose level  of patients with type II diabetes in control group: 
Control  
group 
 
Overall  
score 
 Mean  Mean 
    % 
   SD   Effect   t  test  P  value 
Pre-test 
 
      5     2.933    58.6%   1.172          
 
   4.7 
 
 
   1.756 
          
P>0.05     
    Not  
significant 
post-test 
 
      5     3.166   63.3%   1.085 
  
 The above table reveals that in control group the pre-test mean score was 2.933,mean %  
was 58.6% and standard deviation was 1.172 and in the post- test mean score was 3.166, mean % 
was 63.3% and standard deviation was 1.085 with the decreased effectiveness of 4.7% and 
SDLUHGµW¶WHVWYDOXHRIW 6RLWLVFRQVLGHUHGDVQRWVLJQLILFDQW 
Fig 4.10: Cylindrical diagram showing the effectiveness of amla juice in post prandial blood 
glucose levels of patients with type II diabetes in experimental group and control group: 
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7DEOH  8QSDLUHG µW¶ WHVW VKRZLQJ WKH FRPSDULVRQ EHWZHHQ WKH SRVW SUDQGLDO EORRG
glucose levels in experimental and control group: 
   Group 
 
    Mean     SD       Mean  
Difference 
    µW¶YDOXH Significant 
Experimental 
group 
     25.9     17.60  
    18.9 
 
    13.39 
   P<0.05           
   Highly  
significant Control group 
 
       7        6.89 
 
)LJ&RQLFDOGLDJUDPVKRZLQJ8QSDLUHGµW¶WHVWVKRZLQJWKHFRPSDULVRQEHWZHHQWKH
post prandial blood glucose levels in experimrntal and control group: 
 
 
     
 Thus the interpreted value shown are statistically highly significant, which was observed 
IURPWKHXQSDLUHGµW¶WHVWYDOXHRIZLWKWKH3YDOXHRI 
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SECTION-III:                                                                                                                   
ASSOCIATION BETWEEN DEMOGRAPHIC VARIABLES AND CLINICAL 
VARIABLES WITH THE POST PRANDIAL BLOOD GLUCOSE LEVEL PATIENTS 
WITH TYPE II DIABETES IN EXPERIMENTAL AND CONTROL GROUP: 
Table 4.10 : Association between demographic variables and  post prandial blood glucose 
level of patients with type II diabetes ( experimental group ±pre-test): 
         This section deals with the association between the experimental group of patients with 
type II diabetes pre test post prandial blood glucose level and their gain score with their 
demographic variables. 
                                               Experimental group(pre -test)  
    Demographic    
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Age in years  
30-40 1 3.33 0 0.00 0 0.00 5 16.67 0 0.00 X2 =5.759    
  df=12 
p>0.05  Not 
significant 
41-50 0 0.00 4 13.33 4 13.33 2 6.67 0 0.00 
51-60 2 6.67 1 3.33 4 13.33 3 10.00 1 3.33 
>60 1 3.33 1 3.33 0  0.00 1 3.33 0 0.00 
Gender X2=1.587   
   df=4  
p>0.05 Not  
significant 
Male 2 6.67 2 6.67 4 13.33 6 20.00 0 0.00 
Female 2 6.67 4 13.33 4 13.33 5 16.67 1 3.33 
Marital status     
X2=11.785   
   df=12  
p>0.05 Not  
significant 
Married 3 10.00 3 10.00 6 20.00 6 20.00 1 3.33 
Unmarried 0 0.00 0  0.00 2 6.67 3 10.00 0 0.00 
Divorced 1 3.33 1 3.33 0 0.00 0  0.00 0 0.00 
Widow/Widower 0 0.00 2 6.67 0 .00 2 6.67 0 0.00 
Religion X2=10.24   
   df=12  Hindu 3 10.0 3 10.00 5 16.67 3 10.00 1 3.33 
Christian 0 0.00 2 6.67 2 6.67 8 26.67 0 0.00   p>0.05     
    Not   
significant      
Muslim 1 3.33 1 3.33 0 0.00 0 0.00 0 0.00 
Others 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
Education X2=18.01   
   df=16  
p>0.05 Not  
significant 
Uneducated 0 0.00 0 0.00 2 6.67 0 0.00 0 0.00 
Primary 0 0.00 1 3.33 2 6.67 3 10.00 1 3.33 
High school 2 6.67 1 3.33 2 6.67 3 10.00 0 0.00 
Higher secondary 1 3.33 2 6.67 0 0.00 4 13.33 0 0.00 
Graduate and above 1 3.33 2 6.67 2 6.67 1 3.33 0 0.00 
Income X2=15.895  
   df=12 
p>0.05 Not  
significant 
<5000 3 10.00 3 10.00 2 6.67 3 10.00 1 3.33 
5001-10000 0 0.00 2 6.67 3 10.00 5 16.67 0 0.00 
10001-15000 1 3.33 1 3.33 0 0.00 3 10.00 0 0.00 
>15000 0 0.00 0 0.00 3 10.00 0 0.00 0 0.00 
Occupation X2=5.99   
   df=12  
p>0.05 Not  
significant 
Business 1 3.33 2 6.67 1 3.33 4 13.33 0 0.00 
Govt .employee 1 3.33 1 3.33 2 6.67 2 6.67 0 0.00 
Private sector  2 6.67 1 3.33 3 10.00 3 10.00 0 0.00 
Others 1 3.33 2 6.67 1 3.33 2 6.67 1 3.33 
Dietary habits X2=7.167 
   df=4 
p>0.05 Not  
significant 
Vegetarian 3 10.00 0 0.00 0 0.00 2 6.67 0 0.00 
Non vegetarian 1 3.33 6 20.00 8 26.67 9 30.00 1 3.33 
On regular exercise X2=1.6915   
   df=4  
p>0.05 Not  
significant 
Yes 2 6.67 3 10.00 5 16.67 8 26.67 1 3.33 
No 2 6,67 3 10.00 3 10.00 3 10.00 0 0.00 
 
        The above table showing that none of the demographic variables are significantly associated 
with their post prandial blood glucose level. It was calculated by using pearson chi-square.  
Table 4.11 : Association between demographic variables and  post prandial blood glucose 
level of patients with type II diabetes ( experimental group ±post-test): 
                                               Experimental group(post -test)  
    Demographic    
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Age in years 
30-40 2 6.67 0 0.00 2 6.67 1 3.33 1 3.33 X2 =5.580    
  df=12 
p>0.05  Not 
significant 
41-50 2 6.67 3 10.00 4 13.33 1 3.33 0 0.00 
51-60 3 10.00 3 10.00 2 6.67 2 6.67 1 3.33 
>60 1 3.33 1 3.33 1  3.33 0 0.00 0 0.00 
Gender X2=1.126   
   df=4  
p>0.05 Not  
significant 
Male 4 13.33 3 10.00 5 16.67 1 3.33 1 3.33 
Female 4 13.33 4 13.33 4 13.33 3 10.00 1 3.33 
Marital status     
X2=15.750   
   df=12  
p>0.05 Not  
significant 
Married 6 20.00 4 13.33 6 20.00 2 6.67 1 3.33 
Unmarried 1 3.33 0  0.00 2 6.67 2 6.67 0 0.00 
Divorced 1 3.33 0 0.00 1 3.33 0  0.00 0 0.00 
Widow/Widower 0 0.00 3 10.00 0 0.00 0 0.00 1 3.33 
Religion X2=7.723  
   df=8 
  p>0.05     
    Not   
significant      
Hindu 6 20.00 3 10.00 4 13.33 1 3.33 1 3.33 
Christian 1 3.33 4 13.33 3 10.00 3 10.00 1 3.33 
Muslim 1 3.33 0 0.00 2 6.67 0 0.00 0 0.00 
Others 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
Education X2=17.343   
   df=16  
p>0.05 Not  
significant 
Uneducated 0 0.00 0 0.00 2 6.67 0 0.00 0 0.00 
Primary 1 3.33 2 6.67 2 6.67 2 6.67 0 0.00 
High school 2 6.67 2 6.67 3 10.00 1 3.33 0 0.00 
Higher secondary 2 6.67 2 6.67 0 0.00 1 3.33 2 6.67 
Graduate and above 3 10.00 1 3.33 2 6.67 0 0.00 0 0.00 
Income X2=11.516  
   df=12 
p>0.05 Not  
significant 
<5000 4 13.33 2 6.67 3 10.00 1 3.33 2 6.67 
5001-10000 1 3.33 3 10.00 5 16.67 1 3.33 0 0.00 
10001-15000 2 6.67 1 3.33 0 0.00 2 6.67 0 0.00 
>15000 1 3.33 1 3.33 1 3.33 0 0.00 0 0.0 
Occupation X2=11.374  
   df=12  
p>0.05 Not  
significant 
Business 2 6.67 4 13.33 1 3.33 1 3.33 0 0.00 
Govt .employee 2 6.67 0 0.00 3 10.00 1 3.33 0 0.00 
Private sector  2 6.67 2 6.67 4 13.33 0 0.00 1 3.33 
Others 2 6.67 1 3.33 1 3.33 2 6.67 1 3.33 
Dietary habits X2=4.700 
   df=4 
p>0.05 Not  
significant 
Vegetarian 3 10.00 0 0.00 1 3.33 1 3.33 0 0.00 
Non vegetarian 5 16.67 7 23.33 8 26.67 3 10.00 2 6.67 
On regular exercise X2=0.9619   
   df=4  
p>0.05 Not  
significant 
Yes 6 20.00 5 16.67 6 20.00 3 10.00 2 6.67 
No 2 6,67 2 6.67 3 10.00 1 3.33 0 0.00 
 
    The above table showing the  association between demographic variables and the post test 
level of  post prandial blood glucose level score among experimental group of  patients with type 
II diabetes.None of the demographic variables are significantly associated with their post 
prandial blood glucose level. It was calculated by using pearson chi-square test .   
 
 
 
 
 Table 4.12 : Association between clinical variables and  post prandial blood glucose level of 
patients with type II diabetes ( experimental group ±pre-test): 
 
                                               Experimental group(pre-test)  
        Clinical   
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Duration of illness 
<1year 0 0.00 0 0.00 1 3.33 4 13.33 1 3.33 X2 =14.104   
  df=8 
p>0.05  Not 
significant 
1-2year 0 0.00 1 3.33 1 3.33 4 13.33 0 0.00 
>2year 4 13.33 5 16.67 6 20.00 3 10.00 0 0.00 
Weight in Kgs 
31-40 0 0.00 1 3.33 2 6.67 0 0.00 0 0.00 X2=15.255   
   df=12  
p>0.05 Not  
significant 
41-50 2 6.67 0 0.00 1 3.33 4 13.33 0 0.00 
51-60             2 6.67 2 6.67 2 6.67 6 20.00 0 0.00 
>60 0 0.00 3 10.00 3 10.00 1 3.33 1 3.33 
BMI     
X2=15.255   
   df=12  
p>0.05 Not  
significant 
<18.4 0 0.00 1 3.33 2 6.67 0 0.00 0 0.00 
18.5-22.5 2 6.67 0  0.00 1 3.33 4 13.33 0 0.00 
22.6-29.9 2 6.67 2 6.67 2 6.67 6 20.00 0 0.00 
>30 0 0.00 3 10.00 3 10.00 1 3.33 1 3.33 
Family history of diabetes X2=22.934  
   df=6 
  p>0.05     
    Not   
significant     
Yes:Father 0 0.00 3 10.00 1 3.33 3 10.00 0 0.00 
Mother 0 0.00 1 3.33 5 16.67 0 0.00 0 0.00 
Uncle 1 3.33 0 0.00 0 0.00 1 3.33 0 0.00 
Other relation 0 0.00 0 0.00 0 0.00 2 6.67 0 0.00 
No 3 10.00 2 6.67 2 6.67 5 16.67 1 3.33 
 
Management of illness X2=1.765  
   df=4 
  p>0.05     
    Not   
significant      
Diet& exercise 0 0.00 0 0.00 0 0.00 0 0.00 0 0./00 
Insulin 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
2+$¶V 2 6.67 3 10.00 3 10.00 3 10.00 0 0.00 
Higher secondary 2 6.67 3 10.00 5 16.67 8 26.67 1 3.33 
 
 
          The above table showing the  association between clinical variables and the pre test level 
of  post prandial blood glucose level score among experimental group of  patients with type II 
diabetes. None of the clinical variables are significantly associated with their post prandial blood 
glucose level. It was calculated by using pearson chi-square test .   
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.13 : Association between clinical variables and  post prandial blood glucose level of 
patients with type II diabetes ( experimental group ±post-test): 
 
                                               Experimental group(post -test)  
        Clinical   
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Duration of illness 
<1year 2 6.67 1 3.33 1 3.33 1 3.33 1 3.33 X2 =6.971   
  df=8 
p<0.05  
significant 
1-2year 1 3.33 0 0.00 3 10.00 1 3.33 1 3.33 
>2year 5 16.67 6 20.00 5 16.67 2 6.67 0 0.00 
Weight in Kgs 
31-40 2 6.67 1 3.33 0 0.00 0 0.00 0 0.00 X2=13.539   
   df=12  
p>0.05 Not  
significant 
41-50 2 6.67 1 3.33 2 6.67 2 6.67 0 0.00 
51-60             2 6.67 1 3.33 5 16.67 2 6.67 2 6.67 
>60 2 6.67 4 13.33 2 6.67 0 0.00 0 0.00 
BMI     
X2=13.539  
   df=12  
p>0.05 Not  
significant 
<18.4 2 6.67 1 3.33 0 0.00 0 0.00 0 0.00 
18.5-22.5 2 6.67 1 3.33 2 6.67 2 6.67 0 0.00 
22.6-29.9 2 6.67 1 3.33 5 16.67 2 6.67 2 6.67 
>30 2 6.67 4 13.33 2 6.67 0 0.00 0 0.00 
Family history of diabetes X2=11.670  
   df=16 
  p>0.05     
    Not   
significant     
Yes:Father 3 10.00 1 3.33 2 6.67 1 3.33 0 0.00 
Mother 1 3.33 2 6.67 3 10.00 0 0.00 0 0.00 
Uncle 1 3.33 0 0.00 1 3.33 0 0.00 0 0.00 
Other relation 0 0.00 0 0.00 1 3.33 1 3.33 0 0.00 
No 3 10.00 4 13.33 2 6.67 2 6.67 2 6.67 
 
Management of illness X2=3.336  
   df=4 
  p>0.05     
    Not   
significant      
Diet& exercise 0 0.00 0 0.00 0 0.00 0 0.00 0 0./00 
Insulin 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
2+$¶V 2 6.67 3 10.00 3 10.00 0 0.00 0 0.00 
Higher secondary 2 6.67 4 13.33 6 20.00 4 13.33 2 6.67 
 
 
          The above table showing the  association between clinical variables and the post test level 
of  post prandial blood glucose level score among experimental group of  patients with type II 
diabetes.  Duration of illness is significantly associated with their post prandial blood glucose 
level. The other clinical variables are not significantly associated with their post prandial blood 
glucose level. It was calculated by using pearson chi-square test .   
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.14 : Association between demographic variables and  post prandial blood glucose 
level of patients with type II diabetes ( control  group ±pre-test): 
                                               Control  group(pre -test)  
    Demographic    
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Age in years 
30-40 2 6.67 3 10.00 1 3.33 1 3.33 0 0.00 X2 =14.523   
  df=12 
p>0.05  Not 
significant 
41-50 0 0.00 0 0.00 5 16.67 2 6.67 1 3.33 
51-60 1 3.33 3 10.00 1  3.33 3 10.00 1 3.33 
>60 0 0.00 3 10.00 1  3.33 1 3.33 1 3.33 
Gender X2=5.178   
   df=4  
p>0.05 Not  
significant 
Male 0 0.00 3 10.00 4 13.33 5 16.67 1 3.33 
Female 3 10.00 6 20.00 4 13.33 2 6.67 2 6.67 
Marital status     
X2=8.472   
   df=12  
p>0.05 Not  
significant 
Married 3 10.00 5 16.67 6 20.00 3 10.00 3 10.00 
Unmarried 0  0.00 2 6.67 1 3.33 3 10.00 0 0.00 
Divorced 0 0.00 1  3.33 0 0.00 1 3.33 0 0.00 
Widow/Widower 0 0.00 1  3.33 1  3.33 0 0.00 0 0.00 
Religion X2=2.937 
   df=8 
  p>0.05     
    Not   
significant      
Hindu 1 3.33 6 20.00 5 16.67 5 16.67 1 3.33 
Christian 1 3.33 1 3.33 2 6.67 1  3.33 1 3.33 
Muslim 1 3.33 2 6.67 1  3.33 1  3.33 1 3.33 
Others 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
Education X2=19.193   
   df=16  
p>0.05 Not  
significant 
Uneducated 0 0.00 0 0.00 3 10.00 1 3.33 0 0.00 
Primary 0 0.00 3 10.00 0 0.00 1 3.33 2 6.67 
High school 1 3.33 2 6.67 2 6.67 1 3.33 1  3.33 
Higher secondary 0 0.00 2 6.67 2 6.67 3 10.00 0 0.00 
Graduate and above 2 6.67 2 6.67 1 3.33 1 3.33 0 0.00 
Income X2=8.818 
   df=12 
p>0.05 Not  
significant 
<5000 0 0.00 3 10.00 4 13.33 2 6.67 2 6.67 
5001-10000 1 3.33 3 10.00 3 10.00 1  3.33 1 3.33 
10001-15000 1 3.33 2 6.67 0 0.00 3 10.00 0 0.00 
>15000 1 3.33 1  3.33 1 3.33 1 3.33 0 0.00 
Occupation X2=16.632  
   df=12  
p>0.05 Not  
significant 
Business 1 3.33 3 10.00 1 3.33 0 0.00 0 0.00 
Govt .employee 2 6.67 0 0.00 1 3.33 0 0.00 0 0.00 
Private sector  0 0.00 3 10.00 2 6.67 3 10.00 0 0.00 
Others 0 0.0 3 10.00 4 13.33 4 13.33 1 3.33 
Dietary habits X2=1.909 
   df=4 
p>0.05 Not  
significant 
Vegetarian 0 0.00 1 3.33 2 6.67 1 3.33 0 0.00 
Non vegetarian 3 10.00 8 26.67 6 20.00 6 20.00 3 10.00 
On regular exercise X2=0.1897   
   df=4  
p>0.05 Not  
significant 
Yes 2 6.67 6 20.00 5 16.67 4 13.33 2 6.67 
No 1  3.33 3 10.00 3 10.00 3 10.00 1 3.33 
 
    The above table showing the  association between demographic variables and the pre-test level 
of  post prandial blood glucose level score among control group of  patients with type II diabetes. 
None of the demographic variables are significantly associated with their post prandial blood 
glucose level. It was calculated by using pearson chi-square test .   
 
 
 
 
Table 4.15 : Association between demographic variables and  post prandial blood glucose 
level of patients with type II diabetes ( control  group ±post-test): 
                                               Control  group(post-test)  
    Demographic    
        variables 
Normal  Mild Moderate  Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Age in years 
30-40 1 3.33 2 6.67 3 10.00 0 0.00 1 3.33 X2 =14.212   
  df=12 
p>0.05  Not 
significant 
41-50 0 0.00 0 0.00 4 13.33 4 13.33 0 0.00 
51-60 1 3.33 3 10.00 0 0.00 4 13.33 1 3.33 
>60 0 0.00 1 3.33 3 10.00 1 3.33 1 3.33 
Gender X2=2.624  
   df=4  
p>0.05 Not  
significant 
Male 1 3.33 1 3.33 5 16.67 5 16.67 2 6.67 
Female 1 3.33 5 16.67 5 16.67 5 16.67 1  3.33 
Marital status     
X2=7.267   
   df=12  
p>0.05 Not  
significant 
Married 2 6.67 5 16.67 6 20.00 3 10.00 3 10.00 
Unmarried 0  0.00 2 6.67 1 3.33 3 10.00 0 0.00 
Divorced 0 0.00 1  3.33 0 0.00 1 3.33 0 0.00 
Widow/Widower 0 0.00 1  3.33 1  3.33 0 0.00 0 0.00 
Religion X2=5.667 
   df=8 
  p>0.05     
    Not   
significant      
Hindu 0 0.00 3 10.00 7 23.33 6 20.00 2 6.67 
Christian 1 3.33 1 3.33 2 6.67 2 6.67 1 3.33 
Muslim 1 3.33 2 6.67 1  3.33 1  3.33 0 0.00 
Others 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
Education X2=10.893   
   df=16  
p>0.05 Not  
significant 
Uneducated 0 0.00 1 3.33 2 6.67 1 3.33 0 0.00 
Primary 0 0.00 1 3.33 1  3.33 3 10.00 1  3.33 
High school 0 0.00 2 6.67 2 6.67 2 6.67 1  3.33 
Higher secondary 1 3.33 0 0.00 2 6.67 3 10.00 1  3.33 
Graduate and above 1 3.33 2 6.67 3 10.00 0 0.00 0 0.00 
Income X2=7.412 
   df=12 
p>0.05 Not  
significant 
<5000 0 0.00 2 6.67 4 13.33 4 13.33 1 3.33 
5001-10000 0 0.00 1  3.33 4 13.33 3 10.00 1 3.33 
10001-15000 1 3.33 2 6.67 1 3.33 1 3.33 1 3.33 
>15000 1 3.33 1  3.33 1 3.33 1 3.33 0 0.00 
Occupation X2=10.304 
   df=12  
p>0.05 Not  
significant 
Business 1 3.33 2 6.67 1 3.33 1 3.33 0 0.00 
Govt .employee 0 0.00 2 6.67 1 3.33 0 0.00 1 3.33 
Private sector  0 0.00 1 3.33 3 10.00 4 13.33 1 3.33 
Others 1 3.33 1 3.33 5 16.67 4 13.33 1 3.33 
Dietary habits X2=5.481 
   df=4 
p>0.05 Not  
significant 
Vegetarian 0 0.00 1 3.33 0 0.00 3 10.00 0 0.00 
Non vegetarian 2 6.67 5 16.6
7 
10 33.33 6 20.00 3 10.00 
On regular exercise X2=0.2871   
   df=4  
p>0.05 Not  
significant 
Yes 1 3.33 4 13.33 6 20.00 6 20.00 2 6.67 
No 1  3.33 2 6.67 4 13.33 3 10.00 1 3.33 
 
    The above table showing the  association between demographic variables and the post-test 
level of  post prandial blood glucose level score among control group of  patients with type II 
diabetes. None of the demographic variables are significantly associated with their post prandial 
blood glucose level. It was calculated by using pearson chi-square test .   
 
 
 
 
Table 4.16 : Association between clinical variables and  post prandial blood glucose level of 
patients with type II diabetes ( Control  group ±pre-test): 
 
                                               Control  group(pre-test)  
        Clinical   
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Duration of illness 
<1year 0 0.00 3 10.00 2 6.67 1 3.33 0 0.00 X2 =6.306   
  df=8 
p>0.05  Not 
significant 
1-2year 2 6.67 2 6.67 1 3.33 1 3.33 1 3.33 
>2year 1 3.33 4 13.33 5 16.67 5 16.67 2 6.67 
Weight in Kgs 
31-40 0 0.00 1 3.33 1 3.33 0 0.00 0 0.00 X2=9.827  
   df=12  
p>0.05 Not  
significant 
41-50 0 0.00 1 3.33 3 10.00 1 3.33 1 3.33 
51-60             0 0.00 2 6.67 2 6.67 3 10.00 1 3.33 
>60 4 13.33 5 16.67 2 6.67 3 10.00 1 3.33 
BMI     
X2=8.638   
   df=12  
p>0.05 Not  
significant 
<18.4 0 0.00 1 3.33 1 3.33 0 0.00 0 0.00 
18.5-22.5 0 0.00 1 3.33 3 10.00 1 3.33 1 3.33 
22.6-29.9 0 0.00 2 6.67 2 6.67 3 10.00 1 3.33 
>30 3 10.00 5 16.67 2 6.67 3 10.00 1 3.33 
Family history of diabetes X2=9.892 
   df=16 
  p>0.05     
    Not   
significant     
Yes:Father 0 0.00 2 6.67 1 3.33 2 6.67 1 3.33 
Mother 0 0.00 2 6.67 1 3.33 1 3.33 1 3.33 
Uncle 0 0.00 1 3.33 2 6.67 0 0.00 0 0.00 
Other relation 0 0.00 0 0.00 1 3.33 1 3.33 0 0.00 
No 3 10.00 4 13.33 3 10.00 3 10.00 1 3.33 
 
Management of illness X2=0.1897 
   df=4 
  p>0.05     
    Not   
significant      
Diet& exercise 0 0.00 0 0.00 0 0.00 0 0.00 0 0./00 
Insulin 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
2+$¶V 1 3.33 3 10.00 3 10.00 3 10.00 1 3.33 
Higher secondary 2 6.67 6 20.00 5 16.67 4 13.33 2 6.67 
 
 
          The above table showing the  association between clinical variables and the pre test level 
of  post prandial blood glucose level score among control group of  patients with type II diabetes. 
None of the clinical variables are significantly associated with their post prandial blood glucose 
level. It was calculated by using pearson chi-square test .   
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.17 : Association between clinical variables and  post prandial blood glucose level of 
patients with type II diabetes ( Control group ±post-test): 
 
                                              Control (post -test)  
        Clinical   
        variables 
Normal  Mild Moderat
e 
 Severe Very 
severe 
  Chi-
square 
F   % F  % F    % F   % F   % 
Duration of illness 
<1year 0 0.00 2 6.67 2 6.67 2 6.67 0 0.00 X2 =5.847   
  df=8 
p<0.05  
significant 
1-2year 1 3.33 1 3.33 2 6.67 1 3.33 2 6.67 
>2year 1 3.33 3 10.00 6 2.00 6 2.00 1 3.33 
Weight in Kgs 
31-40 0 0.00 1 3.33 1 3.33 0 0.00 0 0.00 X2=6.935  
   df=12  
p>0.05 Not  
significant 
41-50 0 0.00 0 0.00 2 6.67 3 10.00 1 3.33 
51-60             1 3.33 2 6.67 2 6.67 3 10.00 0 0.00 
>60 1 3.33 3 10.00 5 16.67 3 10.00 2 6.67 
BMI     
X2=6.935 
   df=12  
p>0.05 Not  
significant 
<18.4 0 0.00 1 3.33 1 3.33 0 0.00 0 0.00 
18.5-22.5 0 0.00 0 0.00 2 6.67 3 10.00 1 3.33 
22.6-29.9 1 3.33 2 6.67 2 6.67 3 10.00 0 0.00 
>30 1 3.33 3 10.00 5 16.67 3 10.00 2 6.67 
Family history of diabetes X2=12.114 
   df=16 
  p>0.05     
    Not   
significant     
Yes:Father 0 0.00 2 6.67 1 3.33 1 3.33 2 6.67 
Mother 0 0.00 0 0.00 2 6.67 3 10.00 0 0.00 
Uncle 0 0.00 1 3.33 1 3.33 1 3.33 0 0.00 
Other relation 0 0.00 0 0.00 1 3.33 1 3.33 0 0.00 
No 2 6.67 3 10.00 5 16.67 3 10.00 1 3.33 
 
Management of illness X2=0.2871 
   df=4 
  p>0.05     
    Not   
significant      
Diet& exercise 0 0.00 0 0.00 0 0.00 0 0.00 0 0./00 
Insulin 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 
2+$¶V 1 3.33 2 6.67 4 13.33 3 10.00 1 3.33 
Higher secondary 1 3.33 4 13.33 6 20.00 6 20.00 2 6.67 
 
 
          The above table showing the  association between clinical variables and the post test level 
of  post prandial blood glucose level score among control group of  patients with type II diabetes.  
None of the clinical variables are significantly associated with their post prandial blood glucose 
level. It was calculated by using pearson chi-square test . 
 
 
 
 
 
 
 
 
 
 
 
 
                                   
  SECTION-IV: 
ASSESSMENT OF THE LEVEL OF SATISFACTION: 
                      This  section deals with the assessment of the level of satisfaction among patients 
with type II diabetes in experimental group about amla juice. 
 Table 4.18:  Level of satisfaction 
       No. of  samples    Level of satisfaction Percentage of satisfaction
                   14          Highly satisfied                   47% 
                   14      Moderately satisfied                  47% 
                     2             Satisfied                   6% 
                     0          Not satisfied                   0% 
                   30                   100% 
From above table it showing the level of satisfaction,14(47%) of the samples are highly satisfied 
and are moderately satisfied, 2(6%) of the samples are satisfied. So from this we can conclude 
that satisfactory level was high and also the patients with type II diabetes are satisfied with the 
amla juice. 
                     Fig 4.12 : Pyramidal diagram showing the level of satisfaction
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                                                  CHAPTER  V 
                                                  DISCUSSION  
³7KHonly way to keep your health is to HDWZKDW\RXGRQ¶WZDQWGULQNZKDW\RXGRQ¶WOLNH
DQGGRZKDW\RX¶GUDWKHUQRW´ 
                                                                                              -MARK  TWAIN 
 This chapter discuss the main finding of the research study and reviews that in selection 
the finding from the result of the present study. For \this study the data was obtained regarding 
the effect of amla juice on blood glucose level among patients with type II diabetes in a selected 
area at Namakkal district. 
STATEMENT OF THE PROBLEM: 
                ³ A  STUDY TO ASSESS  THE  EFFECTIVENESS OF  AMLA   JUICE IN  
REDUCING BLOOD  SUGAR AMONG   PATIENTS  WITH  TYPE  II  DIABETES IN A 
6(/(&7('$5($$71$0$..$/',675,&7´ 
OBJECTIVES:  
5) To assess the post prandial blood glucose level of patients with type II diabetes. 
6) To evaluate the effectiveness of amla juice consumption on the level of post prandial 
blood glucose level of patients with type II diabetes.                                                                                     
7) To find out the association between the demographic an  clinical variable with the post 
prandial blood glucose level of patients with type II diabetes.                                                       
8)  To assess the level of satisfaction among patients with type II Diabetes in experimental 
group about  amla  juice  administration.     
 
 
 
1.  To assess  the  post prandial blood glucose level of patients  with  type II diabetes. 
Based on the above objective of the study to assess  the  post prandial blood glucose level 
of patients  with  diabetes mellitus in relation to findings of the experimental and control group 
before and after administration. 
The study  result showing the pre test score of the experimental and control group. In 
experimental group, the  post prandial blood glucose level scoring was 13% in normal, 20% in 
mild, 27% in moderate, 30% in severe, 10% in very sever level. In control group, 10% in normal, 
30% in mild, 27% in moderate, 23% in severe and 10% in very level. 
The post test score of the  experimental group, the  post prandial blood glucose level 
scoring was 27%% in normal, 23% in mild, 30%% in moderate, 13% in severe, 7% in very 
severe levels. In control group, 7% in normal, 20% in mild, 33% in moderate, 30% in severe and 
10% in very levels 
Thus in the experimental group, there is effect on change in the post prandial blood 
glucose level score after post test. But in the control group, there is no change in the post 
prandial blood glucose level score after post test. 
2. To evaluate the effectiveness of amla juice consumption on the level of post prandial 
blood glucose level of patients with type II diabetes.    
7KHFRPSXWHGSDLUHGµW¶ WHVWYDOXH LVDWOHYHOS!GHSLFWV WKDW WKHUH LV D
significant difference between the post prandial blood glucose level among experimental group.                           
7KHFRPSXWHGSDLUHGµW¶WHVWYDOXHLVDWOHYHOSGHSLFWVWKDWWKHUHLVDQR
significant difference between the post prandial blood glucose level among control group.   
7KHFRPSXWHGXQSDLUHGµW¶WHVWYDOXHLVDWOHYHOS!GHSLFWVWKDWWKHUHLVD
highly significant difference between the post prandial blood glucose level among experimental 
and control group.                                                                                                                                                       
3. To find out the association between the demographic an  clinical variable with the post 
prandial blood glucose level of patients with type II diabetes.                                                 
The calculated x2 values of all demographic and clinical variables of experimental group 
are not higher than the tabled value. It showing that non significant association between the 
prandial blood glucose level of patients with type II diabetes in experimental group.   
The calculated x2 values of all demographic and clinical variables of control group are 
not higher than the tabled value. It showing that non significant association between the prandial 
blood glucose level of patients with type II diabetes in control group.  
4. To assess the level of satisfaction among patients with type II Diabetes in experimental 
group about  amla  juice  administration. 
The findings of the level of satisfaction was 47% of the patients were highly satisfied 
with amla juice, 47% were moderately satisfied, 6% were satisfied and none of the patients were 
not satisfied the amla juice. 
RESULTS:      
 In experimental group the pre-test mean score was 2.966,mean percentage was 59% and 
standard deviation was 1.129 and in the post- test mean score was 2.533, mean percentage  was 
50.66% and standard deviation was 1.074 with the effectiveness RI DQGSDLUHG µ W¶ WHVW
value of t=3.971 which was statistically significant (p<0.05) which is an evident for the 
effectiveness of amla juice in reducing blood glucose level. 
 The comparison between, blood glucose levels in experimental and control group, 
VKRZLQJWKHYDOXHDUHVWDWLVWLFDOO\KLJKO\VLJQLILFDQWZKLFKZDVREVHUYHGIURPWKHXQSDLUHGµW¶
test value of 13.39 with the p value of <0.05, which is an evident for the effect of amla juice in 
reducing blood glucose levels. 
 Thereby, the researcher rejecting the null hypothesis 
IMPLICATIONS OF THE STUDY: 
 The findings of the study has implication related to, nursing administration, nursing 
education, nursing practice and nursing research. 
Nursing administration:  
Type  II diabetes mellitus is the commonest form of diabetic globally as well as in India. 
In India, diabetic is not an epidemic any more but has licensed into a pandemic according to the 
international journal of diabetic they labeled India the ³',$%(7(6 &$3,7$L OF THE 
:25/'´ so, increasing demands for quality care at low cost and availability, the nursing 
administrators are in a key position to prepare policies and its execution of quality nursing care 
based on research findings. 
Nursing education: 
Nursing education is a measure for motivating students for knowledge, skill and good 
attitudes for the prevention, promotion, early detection and management of illness. It is essential 
in the wake of recent statistics related to diabetic population in our country is more than 95%. So 
that the nursing educational programs include the theoretical and practical aspect in the 
prevention, promotion and management of diabetic mellitus and prepares the aspiring 
professionals to function effectively. The nurse should be prepared to function in institutional as 
well as in community for promoting the patients with type II diabetes mellitus from the disease. 
The same should be applicable for preparing the nurse at higher levels of nursing education also. 
So, in nursing education syllabus administration of the complimentary therapies for diabetes can 
be included. 
Nursing practice: 
Nursing  should be equipped with updated knowledge as in care of patients with type II 
diabetes. In 1990 St. Vincent declaration was the result of international effects to improve the 
care accorded to those with diabetes. so it is important both in quality of life and life expectancy 
but is also economically expensive due to  diabetic, have been shown to be a  major drain on 
health and productivity related resources for health care systems and governments. 
The researcher can be propagated through mass media to improve the health status of 
patients with type II diabetes and in preventing further complications. The module can be used as 
a guide books by health personnel. So that they can contribute the matter to the  public and make 
control over diabetic with no complications. 
Nursing research: 
Diabetic is a major disease and patients with type II diabetes should get adequate care. 
The study conducted to create an interest to other investigators to carry out further studies. So 
that some of the aspects which are not included in the present study can be more emphasized. So 
the investigator recommends conducting periodic research on diabetic and its control by using 
other complementary therapies as a role of nurses. 
RECOMMENDATIONS: 
¾ A similar study can be under taken on a larger scale for a better generalization. 
¾ The study can be replicated in different settings. 
¾ The study can be conducted to assess the effectiveness of amla juice in the management 
of hyperlipidemia. 
CONCLUSION:  
The study assessed the effect of amla juice in reducing blood sugar level among patients 
with type II diabetes. The result found was that amla juice is having effect in reducing blood 
glucose level after administration of amla juice for the experimental group. By comparing with 
experimental group and control group by pretest and post test, the effect was identified 
(assessed). The study concluded that the amla juice is effective  in reducing blood glucose level. 
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Annexure-2 
/HWWHUVHHNLQJH[SHUW¶VRSLQLRQDQGVXJJHVWLRQIRUWKHFRQWHQW 
Validity of the tool used for the study. 
Form, 
Reg No: 301312904, 
II nd Year M.Sc Nursing, Anbu College of nursing, 
M G R Nagar, Komarapalayam. 
To 
 
 
Forwarded through 
Mrs.Latha, 
Principal,Anbu College of nursing, 
M G R Nagar, Komarapalayam. 
Sub: Expert opinion for content validation of research tool. 
Respected Sir/Madam, 
I Reg No: 301312904 a post graduate student of Anbu College of nursing, anticipate 
<RXUYDOXDEOHVHOILI\RXZRXOGDFFHSWWRYDOLGDWHP\UHVHDUFKWRRORQWKHWRSLF³A Study To 
Assess The Effectiveness Of Amla Juice In Reducing Blood Sugar Among Patients With 
Type Ii Diabetes In A Selected Area At Namakkal District´ 
It would be highly appreciable if you would kindly affirm your acceptance to endorse 
your Valuable suggestions on this topic. I had attached the details of the study along with the 
research tool.sss 
Thanking you 
Date:                                                                                                Yours faithfully. 
Place: Komarapalayam                                                               Reg No: 301312904 
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CONTENT VALIDITY CERTIFICATE 
 
I hereby certify that I have validated the tool of Reg No: 301312904 II nd Year M.Sc 
Nursing  student who is undertaking, A Study To Assess The Effectiveness Of Amla Juice In 
Reducing Blood Sugar Among Patients With Type Ii Diabetes In A Selected Area At 
Namakkal District´ 
 
 
 
 
 
 
Place:                                                                                    Signature and seal of the Expert. 
 
 
 
 
Date:                                                                                         Name and Designation. 
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I.DEMOGRAPHIC VARIABLE PROFORMA  
INSTRUCTION:  
 The  investigator will  be  collecting  the  following  information  from  participants  
(diabetic  patients) interviewing  them. Please be  frank  and  free  in  answer. It  will  be  kept  
confidential  and  will  be  used  for  research  purpose  alone. 
1. Age(in years)  
       a. 30-40        [   ]  
       b. 41-50         [   ]  
       c. 51-60         [   ]  
       d .>60          [   ] 
2.  Gender 
       a. Male        [   ] 
       b. Female        [   ] 
3.  Marital  status 
      a. Married        [   ] 
      b. Unmarried       [   ] 
      c. Divorced       [   ] 
      d. Widow/Widower       [   ] 
4. Religion 
      a. Hindu        [   ]                                                           
      b. Christian       [   ] 
      c. Muslim        [   ]                                                                   
      d. Others        [   ] 
5.  Education 
          a. Uneducated        [   ] 
          b. Primary education      [   ] 
          c. High school education      [   ] 
          d. Higher secondary education     [   ]  
          e. Graduate and above       [   ] 
6.  Income   per  month 
           a.<5000        [   ] 
           b. 5001-10,000       [   ] 
           c. 10,001-15,000       [   ] 
           d. >15,000           [   ] 
7.  Occupation 
           a. Business          [   ] 
           b. Government employee      [   ] 
           c. Private sector        [   ] 
           d.Others       [   ]  
8.  Dietary habits 
           a.Vegetarian        [   ] 
           b.Non-vegetarian       [   ] 
 
9.  On  regular  exercise 
         a. Yes        [   ] 
         b. No        [   ] 
II.  CLINICAL  VARIABLE  PROFOMA            
INSTRUCTION:    
 The  investigator  will  be  collecting  following  information  from  participants  
(Diabetic patients) interviewing  them.  Please  be   frank  and  free  in  answer. It  will  be  used  
for  research  purpose  alone.   
1.Duration  of  illness  
          a.  < 1 year        [  ] 
          b.1-2 years       [  ] 
           c.> 2 years        [  ]  
2.Weight  in  kgs  
          a.31- 40        [  ]                                                                                                
          b.41- 50        [  ] 
          c.51-60        [  ]                                                                    
          d.> 60        [  ]                                                                    
3.Basal  metabolic  index  
          a. <  18.4       [  ] 
          b. 18.5-22.5       [  ] 
          c. 22.6-29.9        [  ] 
          d. > 30        [  ] 
4. Family  history  of  Diabetes 
         a. yes         [  ]                                       
         b. No         [  ]                                             
 
LI\HVVSHFLI\WKHUHODWLRQVKLS«                             
1.father        [  ]                                                                    
2.mother        [  ]                                                                    
3.uncle        [  ]                                                                    
4.other relations      [  ] 
5. Management  for  illness  (Diabetes) 
a.Diet & exercise      [  ]                                                                    
b. Insulin       [  ]                                                                    
c.Oral hypoglycemic agents      [  ]                                                                    
d.All the above      [  ]     
                                          
 
                           
 
 
 
 
  III. BLOOD  GLUCOSE  ASSESSMENT  CHART: 
 PURPOSE:  
 This assessment chart is used to record the post prandial  blood glucose before and 
after administration of amla juice. 
INTRODUCTION: 
 The researcher will document the blood glucose levels after checking with the 
glucometer. 
 
               variable  
 
  
 
Post prandial blood glucose  
 
      [Mg/dl] 
Before administration           
baseline data 
After administration 
 of amla juice 
     Date   Clients value    Date 15thday  
[clients value] 
    
                           
 SCORING:                                 
                  <140mg/dl[normal] .                                                                                                                                 
      140-210 mg/dl [mild]. 
                   211-280 mg/dl [moderate].                                                                                                                      
                   281-350 mg/dl [severe]. 
                    >350 mg/dl [very severe]. 
 
IV. RATING  SCALE   ON  PATIENTS  SATISFACTION  ABOUT  AMLA  JUICE  
ADMINISTRATION:  
PURPOSE:  
This  rating  scale  is  used  to  assess  the  level  of  satisfaction  among  diabetic  patients 
regarding  amla  juice  administration  and  this  is assessed  by  the  researcher   after  the  
therapy. 
INSTRUCTION: 
There  are  5  items  given  below.kindly  read  the  items.responses  extent  from  highly 
satisfied to not-satisfied. Describe your satisfaction  amla  juice administration.Give  your  
responses  freely  and  frankly  ,the  responses  will  be  kept  confidential.  
S.No      Items Highly 
satisfied 
Moderately 
satisfied 
Satisfied 
         
Not 
satisfied 
     4        3       2    1 
    1  
 
Frequency of 
administration 
    
    2 
 
Duration of 
administration 
    
    3 
 
Taste of amla  
juice 
    
    4 
 
Amout of amla  
juice 
    
    5 Cost     
 
SCORING:< 25%    -   Not satisfied. 
                   25-50% -   Satisfied. 
                   51-75% -   Moderately satisfie  
                    >75%     -   Highly satisfied.  
gFjp - I 
r%fk; rhh;e;j Ra tptuf; Fwpg;G 
Fwpg;G: 
Ma;thsh; gq;Nfw;ghsh;fsplkpUe;J (ePhpopT Nehahspfs;) 
fPo;fhZk; jfty;fis Ngl;b fhz;gjd; %yk; Nrfhpf;fwhh;. 
jaT$h;e;J gakpy;yhkYk; ,ay;ghfTk; tpilaspf;fTk;. ,J 
ufrpakhd Kiwapy; fhf;fgLk; kw;Wk; ,J Ma;Tf;F kl;LNk 
cgNahfg;gLj;jg;gLk;. 
1. taJ ( tUlq;fspy; ) 
    i.  30 - 40         [     ]                                 
    ii. 41 - 50         [     ]                                
    iii. 51 - 60         [     ]                                
    iv. 60 f;F Nky;        [     ]                                        
2. ghypdk;            
    i.  Mz;          [     ] 
    ii.    ngz;         [     ]  
3. jpUkzepiy            
    i.  jpUkzkhdth;        [     ]               
    ii.  jpUkzkhfhjth;        [     ]   
    iii. tpthfuj;jhdth;         [     ] 
    iv.   tpjit                [     ] 
4. kjk; 
    i.   ,e;J                 [     ] 
    ii.    fpwp];Jtk;                [     ] 
    iii. kw;wit                [     ] 
5. fy;tpj; jFjp 
    i.  gbg;gwptpy;yhjth;               [      ] 
    ii. Muk;gepiyf; fy;tp                [      ] 
    iii. cah;epiyf; fy;tp               [      ] 
    iv. Nky; epiyf; fy;tp              [      ] 
    v.   gl;lk; kw;Wk; mjw;F Nky;             [      ] 
 
 
6. khj tUkhdk; ( &ghapy; ) 
    i.   5000 f;F fPo;        [     ] 
   ii.  5001  - 10000        [     ] 
   iii. 10001 - 15000        [     ]  
   iv. 15001 f;F Nky;        [     ] 
7. njhopy; 
   i.  Ranjhopy;         [     ] 
   ii.  muR Copah;         [     ] 
   iii.  jdpahh; epWtdk;        [     ] 
   iv.  kw;wit         [     ] 
8. czT gof;fk; 
   i.   irtk;         [     ] 
   ii.  mirtk;         [     ] 
9. jpdrhp clw;gapw;rp Nkw;nfhs;tPh;fsh ? 
   i.  Mk;          [     ] 
   ii.  ,y;iy         [     ] 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
gFjp - 2 
Neha; njhlh;ghd tptuk; 
 tprhuiz elj;Jgth; gq;Nfw;ghsh;fsplkpUe;J  ( ePhpopT 
Nehahspfs; ) fPo;f;fhZk; jfty;fiy Ngl;b fhz;gjd; %yk;  
Nrfhpf;fpwhh;. jaT$h;e;J   gakpy;yhkYk;     ,ay;ghfTk;  
tpilaspf;fTk;. ,J ufrpakhd Kiwapy; fhf;fgLk; kw;Wk; ,J  
Muha;r;rpf;F kl;LNk cgNahfg;gLj;jg;gLk;. 
 
1. cly; eyf; NfL vj;jid ehl;fshf cs;sJ ? 
     i.  xU tUlj;jpw;F Fiwthf      [     ] 
     ii.    1 - 2 tUlk;        [     ]   
     iii. ,uz;L tUlj;jpw;F Nkyhf       [     ] 
2. cly; vil ( fpNyh fpuhk; )  
     i.    31 - 40         [     ] 
     ii.   41 - 50         [     ] 
     iii.  51 - 60         [     ] 
     iv. 60 f;F Nky;        [     ] 
3. mbg;gil caph;g;nghUs; khWghl;L ml;ltiz  
     i.   < 18.4         [     ] 
     ii.     18.5 - 22.5        [     ] 
     iii.    22.6 - 29.9        [     ] 
     iv.     30          [     ] 
4. cq;fs; FLk;g egh;fspy; ahUf;NfapDk; ePhpopTNeha; cz;lh ? 
     i.      Mk;         [     ] 
     ii.  ,y;iy         [     ] 
           i. Mk; vdpy;. cwTKiw  
              1. mg;gh        [     ] 
              2. mk;kh        [     ] 
              3. khkh        [     ] 
              4. kw;w cwTKiw      [     ] 
 
 
 
5. ePhpopTNeha;f;F cgNahfg;gLj;Jk; kUj;Jfs; 
     i.   czTf; fl;Lg;ghL kw;Wk; clw;gapw;rp    [     ] 
    ii.    ,d;Rypd;         [     ] 
    iii.   Xuy; i`g;NghfpisrPkpf; Vn[z;l;]; (OHA'S)   [     ] 
    iv.  kw;Wk;         [     ] 
 
 
 
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
gFjp - 4 
    ney;ypr;rhW rpfpr;ir gw;wpa gq;Nfw;ghshpd; kd epiwT mwpjy; 
Fwpf;Nfhs;: 
    ney;ypr;rhW rpfpr;ir gw;wpa gq;Nfw;ghshpd; kd epiwT mwpjy; 
Fwpg;G:  
    Ie;J tifahd tpdhf;fSk; mjw;Fhpa gjpyhf epiwe;j  
kdepiwT Kjy; kdepiwT mw;w epiy tiu nfhLf;fg;gl;Ls;sJ 
mij ftdkhf gbj;J tpilaspf;fTk;.      nfhLf;fg;gl;l 
ml;ltizia ftdkhf gbj;J ,ay;ghfTk;   gakpy;yhkYk; 
tpilaspf;fTk;. ,J ufrpakhd Kiwapy; fhf;fg;gLk; kw;Wk; ,J 
Ma;Tf;F  kl;LNk cgNahfg;gLj;jg;gLk;. 
 
 
t. 
vz; 
 
 
nghUs; 
Mjpfkhd 
kd 
epiwT 
kpjkhd 
kd 
epiwT 
kd 
epiwT 
kdepiwT 
mw;w 
epiy 
      4    3          2     1 
1. Mbf;fb vLj;Jf; 
nfhs;Sjy; 
    
2. vLj;Jf;nfhs;Sk; 
fhyk; 
    
3. ney;ypr;rhW 
Rit 
    
4. ney;ypr;rhW  
msT 
    
5. tpiy     
 
kjpg;ngz;: 
25 f;F fPo;       - kd epiwT mw;w epiy 
25  - 50         - kd epiwT  
51  - 75         - kpjkhd kd epiwT 
76 f;F Nky;      - mjpfkhd kd epiwT 
 
 
 
 
 
  
